Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi

 

/    

/ 

Aethoxyskelerol
(polidocanol)
1%, 2 ml
3%, 2 ml

- ก !"#$!%&'()'( (sclerosing of
varicosevein) 2 mg/ kg/ day
Intravariceal, Paravariceal
Direct IV, IV Infusion

Acetylcysteine
(Fluimucil)
Inj : 300 mg/ 3 ml
Oral : 200 mg/
Sachet

- Antidote E paracetamol 300 mg/ kg
FJX>:8# 3 A@> 150, 50 F%D 100 mg/ kg
? 9%Y (J
- :$!(Mก:8# 5% solution :$)$ ( 140 mg/ kg
? 9(#IE)$ ( 70 mg/ kg 3\ก] 4 ;9. L$AJ
17 dose
IV Infusion
- Antivirus: 5 - 10 mg/ kg :8#$ $กIX 1 ;9.
3\ก ] 8 ;9. $ $ 5 - 7 I$
- :$!(MกA=(? 9f&@$34_b=I 250 mg/ m2 :;#
5 mg/ kg F%D 500 mg /m2 :;# 10 mg/ kg

Acyclovir
250 mg, 500 mg,
1 gm ; powder
(Zovirax)

Amikacin (Amikin)
500 mg/ 2 ml

IV Infusion
- Antibiotic (amminoglycoside)
- )$ (E 5 - 7.5 mg/ kg 3\ก12 ;9.
- )$ (:;#E I9?X'I$G9X!ก=$ 15 mg/ kg 8&'
1.5 gm :$A$'#I$
IM, Intermittent IV   

!

-

D5W

- Direct IV : 3 - 5 $ 34
- IV Infusion : 30 - 60 $ 34

7$8  1:
A@>34_ 1: $ $ 15 $ 34
150 mg/ kg in 200 ml D5W A>@ 34_ 2: $ $ 4 ;9.
7$8  2 :
A>@ 34_ 3: $ $ 16 ;9.
50 mg/ kg in 500 ml D5W
7$8  3 :
100 mg/ kg in 1,000 ml D5W

D5W, D5S/2
- %D% E 250 mg :$$@Y ก%_$
D5S/4, D5S, NSS, 10 ml
RINGER
- %D% E 500 mg :$$@Y ก%_$
10 ml
- %D% E 1 gm :$$@Y ก%_$
20 ml
D5W, D10W, NSS
, D5S, D5S/2,
RINGER 

!L&'L >:$" %D% E34_:;#G(#
100 - 200 ml

:8#E ;# ] B E:$ 60 $ 34
!f&_'3Y :8#!ก=(AI 9!"4E8 E
?X' renal tubular $#'E34_"\(

30 - 60 $ 34 

" #/ $
- 8# 9:;#:$8<=>?@>ABCDED 3 !(&'$Fก, :$A$G)#94HDI?=
8'J8&(, KAG?, KA8I:L, !"#$!%&'(F)M>, AI 9($"N>
- Discard any unused solution.
- USFDA Preg Cat B
- 8%>%D% EF%D!L&'L >!กMJG(# 24 )9.
- AI:8#8%>G(#JE paracetamol overdose 8 - 15 ;9
- !ก=(I=>!I4E$, 8$ I"_$, 8%'(%9?4JHI(a4D 8N'&@' b&_$A$
- !ก=( anaphylactic reaction G(#$#'E
- USFDA Preg Cat B
- 8%>%D% EAI:;#B E:$ 12 ;9. (E G9X94 preservative)
- 8%>b"9E F%#IG9XAI!กMJGI#:$?N#!EM$!f D' L?ก?Dก'$G(#
- :8#$@Y !f4E>f' (2000 - 3000 ml/ day) Hl'>ก$ crystaluria
:$;XI> 2 ;9. Fก
- %()$ (E F%D!f=_9;XI>DED!I% :8#:$A$G)#34_94 Cr
clearance 50 ml/ min/ 1.73 m2 8&'$#'EกIX
- USFDA Preg Cat B
- A>?I 24 ;9. 34_'\m8BN9=8#'> F%D 24 ;9. :$?N#!EM$
- DI>ก :;#:$A$G)#KAG?, KA?J, bN#"N>' E\34_G(#JE :$
;$ ("N>] F%D:;#?=(?X'ก$!Hn$DED!I% $ $, A$G)#) ($@Y
- ?IL"'Jก G(#E=$)'>8N
- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Aminophyllin
250 mg/ 10ml 

/    

/ 
- Bronchial asthma, Bronchodilator
- Loading 5 mg/ kg
- bN#HpIE CHF = 0.3 mg/ kg/ hr
- Normal = 0.6 mg/ kg/ hr
- Smoker = 0.9 mg/ kg/ hr  

D5W, D10W,
0.45%NaCl, NSS,
RINGER

Direct IV (G9X$=E9:;#!$&_'>L กก :8#!MI!ก=$GH
' L3Y :8#!"4E;4I=?G(#), IV Infusion
Amphotericin B
(Fungizone )
50 mg ; powder

- Antifungal !=_9?#$ 0.25 mg/ kg F%D
!f=_9!Hn$ 0.7 t 1.5 mg/ kg/ day "N>"\(G9X!ก=$
1.5 mg/ kg/ day [G9X!ก=$ 50 mg/ day]

D5W 

!
- Direct IV : :8# loading dose
:$ 20 - 30 $ 34
(G9XAI:8#!MI!ก=$ 25 mg/ min,
8 ก!ก=(' ก )# >!A4E>
AI8E\(กX'$ 5 t 10 $ 34
F%#I:8#?X':$'? !MI34_%(%>)
- IV Infusion : G9X:8#!ก=$
25 mg/ min
%D% Eb>E 50 mg :$ D5W
250 - 500 ml 

20 t 30 $ 34

:8#$ $ 2 - 6 ;9. 

NSS 
Ringer Lactate
Ampicillin
250 mg, 1gm ;
powder

IV Infusion
- Antibacterial 1 - 2 gm 3\ก 4 - 6 ;9.
G9X!ก=$ 12 gm/ I$

IM, Direct IV, IV Infusion

D5W, D5S/2, NSS, - IM : 250 mg, 1 gm :$$@Y ก%_$
RINGER
0.9 ml F%D 3.4 ml ? 9%Y (J
- Direct IV : %D% E 250 mg :$
$@Y ก%_$ 5 ml F%D 1 gm :$$@Y
ก%_$ 7.4 ml
- IV Infusion : :$" %D% E34_G(#
'EX >$#'E 50 ml

- IM : 3 - 5 $ 34
- Direct IV : :8#;# ]
'EX >$#'E 3 t 5 $ 34
y# )$ (E 500 mg F%D
8 กAI 9F>9 กกIX $@$
:8#$ $ 10 t 15 $ 34 

" #/ $
- 8%>!L&'L >F%#IAI:;#B E:$ 24 ;9. !9&_'!กMJ:$?N#!EM$
- DI> DI กJ Cimetidine, Ciprofloxacin, Erythromycin,
Clarithromycin
ก  ! : vital sign F%D side effect L กE !;X$
nervousness, anxiety, tachycardia, A%&_$G"#, ' !L4E$

- USFDA Preg Cat C
- Test dose : :8#E 3 > IV :$)$ ( 0.1 mg/ kg [)$ (E
"N>"\(G9X!ก=$ 1 mg] infuse $ $ 30 t 60 $ 34
- ?=(? 9 : fever, pulse rate , BP 3\ก 30 $ 34
$ $ 4 ;9. y# 94' ก กX'$:8#E A@>?X'GH
- G9XAI:8#E $ $!ก=$ 5 I$
- 8# 9b"9:$ NSS, Ringer lactate
- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> 8&'
1 "H( 8C:$?N#!EM$
- USFDA Preg Cat B
- 8%>%D% EF%#I AI:;#B E:$ 1 ;9. 8&' 48 ;9. (8 ก?I3Y
%D% E!Hn$ NSS)
- A$G)#34_G?G9X(4 ?#'>%()$ (E %>

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/    

!

Amiodarone
(Cordarone)
150 mg/ 3ml

- ก B ID Ventricular fibrillation F%D unstable
ventricular tachycardia
)$ (ก :8#E :$ 24 ;9. Fก )'>ก :8#E HD9 m
1000 mg FJX>:8#E !Hn$ 3 DED (>$4@
:$ 24 ;9. Fก
1. Rapid loading phase : $Y E 150 mg 9 !L&'L >(#IE
D5W 100 ml :8#:$!I% 9 กกIX 10 $ 34 '? !MI
15 mg/ $ 34 '? !MI"N>"\(G9X!ก=$ 30 mg/ $ 34
2. Slow loading phase : $Y E 34_!L&'L >F%#I9 360 mg
:8#:$!I% 6 ;9. '? !MI 1 mg/ $ 34
3. Maintenance infusion : $Y E 34_!L&'L >F%#I9 540
mg :8#:$!I% 18 ;9. '? !MI 0.5 mg/ $ 34
8%>L ก 24 ;9. F%#I:8#E !Hn$ :
Maintenance infusion : K(E:8#" %D% E34_!L&'L >F%#I
:$AI 9!)#9)#$ 1 t 6 mg/ ml :8#:$!I% 24 ;9. K(E94
'? !MI 0.5 mg/ $ 34 '? !MI' L!f=_9G(#? 9ก 
?'J"$'>?X'E
- :$กm434_:;#AI 9!)#9)#$9 กกIX 2 mg/ ml ?#'>:8#bX $
3 > Central venous catheter

D5W

- Rapid, Slow, Maintenance :;#
150 mg, 360 mg, 540 mg
:$ D5W LY $I$ 100 ml,
200 ml, 300 ml ? 9%Y (J
:$ 24 ;9. Fก :
- Rapid loading phase :
$Y E 150 mg 9 !L&'L >(#IE D5W
100 ml
- Slow loading phase :
F%D Maintenance infusion 18 ml
(6 amp) )'> Amiodarone 9 !L&'
L >(#IE D5W 500 ml G(#AI 9
!)#9)#$ 1.8 mg/ ml (900 mg/ 500
ml)
8%>L ก 24 ;9.:
- Maintenance infusion : :;#)$ (
E 34_?#'>ก 9 !L&'L >(#IE D5W
:8#G(#AI 9!)#9)#$ 1 t 6 mg/ ml
- " %D% E34_!L&'L >:$ D5W 34_
AI 9!)#9)#$ 1 t 6 mg/ ml !9&_''ENX
:$)I(Fก#ILD94' E\$ $ 24 ;9. y#
'ENX:$ Polyvinyl Chloride LD94' E\
2 ;9. 

- 1.5 mg/ $ 34
!I% 10 $ 34
- 1 mg/ $ 34
!I% > 6 Hr
- 0.5 mg/ $ 34
!I% > 186 Hr 

" #/ $
- y# " %D% E!L&'L >JL\:$B ;$Df% "?=ก PVC AI:;#
B E:$ 2 ;9. F%D" %D% E!L&'L >JL\:$B ;$DFก#IAI:;#
B E:$ 24 ;9.
- !กMJE :$'\m8BN9=?_Y กIX 25 '>a F%DHl'>ก$F">
- DI>ก :;#:$"?494ABC, :;#XI9กJE 34_3Y :8#!ก=( Torsades
de pointes 8%4ก!%4_E>ก :;#E :$!(Mก' E\?_Y กIX 2 H| F%D8# 9
:;#:$!(Mก3 กFก!ก=( 
7$
- G9XAI:;#E IV Amiodarone !Hn$!I% $ $9 กกIX 3 "H( 8C
- G9XF$D$Y :8#}4(E !)# 8%'(!%&'((Y K(E?> (AIกD3Y
!}f D:$กm4}\ก!}=$!3X $@$) !$&_'>L ก94AI 9!"4_E>!ก4_EIกJก 
G8%!I4E$ F%DAI 9($)'>K%8=? !;X$ AI 9($K%8=??_Y 'EX > 
\$F> DJJก G8%!I4E$K%8=?%#9!8%I y# !Hn$GHG(#AI 9:8#E
K(E IV Infusion 'EX >;# ] !9&_'?#'>ก !H%4_E$L กE }4(!Hn$ 
JHD3 $
- 8 ก:;#E }4(!Hn$DED!I% $#'EกIX 1 "H( 8C JHD3 $
)$ ( 800 t 1600 mg/ I$
- 8 ก:;#E }4(!Hn$DED!I% 1 t 3 "H( 8C JHD3 $ )$ (
600 t 800 mg/ I$
- 8 ก:;#E }4(!Hn$DED!I% 9 กกIX 3 "H( 8C JHD3 $
)$ ( 400 mg/ I$ 
ก@A : กDI$กDI E "J"$ 9~$>> AI 9($K%8=??_Y
8I:L!?#$!MI ;ก
- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/    

!  

" #/ $

Atropine sulfate
Inj. 0.6 mg/ ml

- :;#:$ Sinus bradychadia, heart block, asystole, idioventricular, slow junction rhythms
(cholinergic blocking agents) ก B ID sinus bradycardia, antidote )'>" f=fIก
organophosphate 
ก
ก :
- Preanesthetic : Oral, IM, IV, SC : $@Y 8$ก < 5 kg: 0.02 mg/ kg/ dose
:8#กX'$bX ?( 30 - 60 $ 34 ' L:8#?X'3\ก 4 t 6 ;9. ? 9AI 9LY !Hn$
$@Y 8$ก > 5 kg : 0.01 t 0.02 mg/ kg/ dose y~>)$ ("N>"\( 0.4 mg/ dose กX'$bX ?(
30 t 60 $ 34 )$ (?_Y "\( 0.1 mg
- Bradycardia : IV, intratracheal : 0.02 mg/ kg )$ (?_Y "\( 0.1 mg )$ ("N>"\(?X'A@> 0.5 mg
:$!(Mก F%D 1 mg :$bN#:8<X ' L:8#€@Y G(#3\ก 5 $ 34 L$G(#)$ (E I9G9X!ก=$
1 mg :$!(Mก F%D 2 mg :$bN#:8<X
- Bronchospasm : Inhalation : 0.03 t 0.05 mg/ kg/ dose I$%D 3 t 4 A@> 
:
- Asystole : IV ; 1 mg €@Y G(# 3\ก 3 t 5 $ 34? 9AI 9LY !Hn$
- Preaneathetic : IM, IV, SC ; 0.4 t 0.6 mg กX'$bX ?( 30 t 60 $ 34 :8#€@Y G(#3\ก 4 t 6 ;9.
- Bradycardia: IV ; 0.5 t 1 mg 3\ก 5 $ 34 Total. Max 2 mg 8&' 0.04 mg/ kg
- B ID Neuromuscular blockade : IV 25 t 30 mcg/ kg :8#กX'$:8#E Neostigmine
30 I=$ 34
- Bronchospasm : inhalation : 0.025 t 0.05 mg/ kg/ dose 3\ก 4 t 6 ;9.
()$ (E "N>"\( 5 g/ dose)
- f=L ก Organophosphate 8&' Carbamate : IV 1 t 2 mg/ dose 3\ก 10 t 20 $ 34 L$กIX LD
!ก=( atropine effect ?X'GH:8#E 3\ก 1 t 4 ;9. !Hn$!I% 'EX >$#'E 24 ;9. )$ (E I9"N>"\( 50
mg :$ 24 ;9. Fก กm4 severe intoxication ' L:8#)$ (E I93@>89("N>y~> 2 g

- 8# 9b"9กJ IV solution
- :$ Cadiac asystole $@$ total dose
G9XAI!ก=$ 2.5 mg :$ 2 ;9. A~_>
- E ' L94"XI$b"9)'> Sodium
metabisulfite €~_>' LกX':8#!ก=(ก 
Ff#G(#
- ก :;#E :$)$ (?_Y ] (0.1 mg) ' L
3Y :8#!ก=( paradoxical bradycardia
G(#
- G9XAI:8#y# heart rate >
60 beat/ min 
ก overdose : dilated,
unreactive pupils, blurred vision,
dryness of mucous membrane,
urinary retention, tachycardia,
hyperthermia, hypertension
กกE$กA : !กMJ34_'\m8BN9=
?_Y กIX 30 '>a !€%!€4E" 8# 9F;XF)M>
F%D!กMJ:8#f#$F">
- ">!ก?' ก  tachycardia y# bN#HpIE
94KA8I:LXI9(#IE

IM, IV, SC

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Atracurium
besylate
(Tracium)
25 mg/ 2.5 ml 

/    

/   

- !Hn$ neuromuscular blocker of choice "Y 8JbN#HpIE NSS, D5W,
34_94B IDก 3Y > $)'>?J8&'G?JกfX'> :;#"Y 8J
D5S
A% Eก%# 9!$&@'!f&_'ก :"X endotracheal tube 8&':$ ก
ก bX ?( G9X943‚=ƒD>JHI(
Lactate

ก 1 
 2  :
Ringer Sol.
!=_9?#$:8# 0.3 t 0.4 mg/ kg, maintenance dose 0.25
mg/ kg

ก > 2   :
!=_9?#$:8# 0.4 t 0.5 mg/ kg , maintenance dose
0.08 t 0.1 mg/ kg 8%>ก :8#E A@>Fก 20 t 45 $ 34
' L:8#€@Y G(# 3\ก 15 t 25 $ 34 
D8IX >bX ?( ; !=_9?#$ 9 t 10 mcg/ kg/ min,
maintained rate 5 - 9 mcg/ kg/ min
ICU ; Continuous IV : infusion 11 - 13 mcg/ kg/ min 

!  

" #/ $

- Direct IV ' LG9XLY !Hn$?#'>
!L&'L >E
- Intermittent infusion F%D
continuous infusion !L&'L >E
(#IE D5W 8&' NSS, D5NSS
(8# 9!L&'L >:$ LRI) K(E:;#
20 mg (2 ml) !L&'L >:$
" %D% E 98 ml LDG(#AI 9
!)#9)#$ 200 mcg/ ml (0.2 mg/
ml) 8&':;# 50 mg (5 ml) !L&'L >
:$" %D% E 95 ml. LDG(#AI 9
!)#9)#$ 500 mcg/ ml ( 0.5 mg/
ml )

- Direct IV :;#!}f D!9&_'
!=_9?#$:8#E !Hn$ loading
dose !3X $@$ K(E:8#E bX $
3 >" E:8#" $@Y 3 >8%'(
!%&'((Y :;#!I% 30 t 60
I=$ 34
- Intermittent Infusion : :8#
E 34_!L&'L >bX $3 >" E:8#
" $@Y K(EH%X'E" $@Y 34_!)#
ก$G(#กJE :8#G8%!)# GH
f#'9กJE
- Continuous infusion : :;#
"Y 8Jก bX ?(34_:;#
!I% $ $ K(E:;#8%>L กก 
:8#FJJ direct injection K(E
:8#:$'? !MI
5 t 10 mcg/ kg/ min

- Initial bolus ' LG9X?#'>!L&'L >
- :8#3 > IV !3X $@$ G9XAI:8#3 > IM !$&_'>L กLD3Y :8#!ก=(
Tissue Irritation
- 8%>L ก!L&'L >F%#IA>?I 24 ;9. 34_'\m8BN9=?N#!EM$8&'
'\m8BN9=8#'>
- A$G)#' L94AI 9($?_Y ?IF(> !f D94ก 8%_>)'>
Histamine F%D' L!ก=( Bronchospasm G(#F?XfJG(#$#'E 
7$ :
- AI!?4E9E F%D!A&_'>9&'!f&_'"Y 8J;XIE;4I=?GI#
:$กm4}\ก!}=$
- y# :;#XI9กJ Isoflurane 8&' Enflurane AI%()$ (E
Atracurium %> 33 % , y# :;#XI9กJ Halothane AI%()$ (
E Atracurium %> 10 %
- :$ก :8#E AI:;#กJ!A&_'> Infusion pump
- AIDI>ก :;#E :$bN#HpIE34_94B ID Electrolyte Imbalance
8&' Dehydration €~_>LD3Y :8#!ก=(ก ''ก3‚=ƒ)'>E !H%4_E$GH
ก  ! : Vital signs ?IL?=(? 9D(J)'> muscle
relaxation F%DB IDก 3Y > $)'>?JF%DG? (กm4:;#:$
ICU)
F overdose : Respiratory depression, cardiovascular
collapse 

! IV $ % &

Direct IV, IV Infusion

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Benztropine
(Cogentin)
2 mg/ 2 ml

Cloxacliin
500 mg, 1 gm ;
Powder

Cotrimoxazole
(Sulfamethoxazole
400 mg +
Trimethoprim
80 mg )/ 5 ml 

/    

/   

- Central Anticholinergic drug
- :$กm4 Drug t induced EPS

ก > 3  : 0.02 t 0.05 mg/ kg/ dose :8#I$%D 1
t 2 A@> 
: 1 t 4 mg/ dose :8#I$%D 1 t 2 A@>
- :$กm4 Acute dystonia
bN#:8<X : IM, IV ; 1 t 2 mg
IM, Direct IV
- Antibiotic (Penicillins)
- )$ (ก :8#E 500 mg t 1000 mg
3\ก 6 ;9.

-

IM, Direct IV, IV Infusion
- Antibiotic (Sulfa Groups) 
> 2 
 
- )$ (ก :;#E 3_IGH 8 t 12 mg )'> TMP/ kg/ day
FJX>:8#3\ก 6 ;9.
- UTI (Max 4 I$), Shigellosis (Max 5 I$) :8#E 8 t
10 mg )'> TMP/ kg/ day FJX>:8#3\ก 6, 8 8&' 12 ;9.
- Pneumocystic :8#E 15 t 20 mg )'> TMP/ kg/ day
FJX>:8#3\ก 6 8&' 8 ;9.
- Sepsis (adults) :8#E 20 mg )'> TMP/ kg/ day FJX>
:8#3\ก 6 ;9.
IV Infusion 

!
- :8#E G(#K(EG9X?#'>!L&'L > 

1 mg/ min

D5W, D5S, NSS - IM : %D% EE 250 mg :$$@Y ก%_$ - Direct IV : 3 t 4
(0.9%NaCl)
1.5 ml
$ 34
- Direct IV : %D% EE 500 mg :$ - Infusion : 1 - 3 ;9.
$@Y ก%_$ 8 - 10 ml
- Infusion : %D% EE :$" %D% E
34_:;#G(#'EX >$#'E 100 ml
NSS, D5W,
- !L&'L > : 1 amp :$" %D% E34_:;#
G9X!ก=$ 1 ;9. A~_>
D10W, RINGER G(#'EX >$#'E 125 ml ' L:;#!f4E> 75 (K(E3_IGH 60 t 90
ml G(#:$ E34_?#'>LY ก(H=9 m$@Y
$ 34) 

! IM 
Rapid
Direct IV 

" #/ $
- $=E9:8#3 > IM
- ?#'>AIJA\9G9X:8#!ก=( electrolyte imbalance F%D
fluid imbalance DI> sign of anticholinergic toxicity
!;X$ H กF8#>, 3#'>bNก, ก%# 9!$&@''X'$F>, tachycardia

- USFDA Preg Cat C
- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> F%D 4 I$:$
?N#!EM$
- AI:8#3 > IV Infusion ;# ] %(' ก HI(F%DHl'>ก$ก 
!ก=( Phlebitis
- USFDA Preg Cat B
- 8%>!L&'L >F%#IF%#IAI:;#B E:$ 6 ;9. y# " %D% E
!Hn$ D5W 94AI 9A>?I 24 ;9
- AI 9!)#9)#$"N>"\(34_%D% EG(#A&' 2 amp ?X'" %D% E
100 ml AI:;#B E:$ 2 ;9
- AI?IL CBC, LFT, renal function test, urinalysis

- USFDA Preg Cat C,D at near term

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/ 

Calcium gluconate - Hl'>ก$F%Dก B ID hypocalcemia, :;#"Y 8J
10% , 10 ml
tetany, cardiac disturbances L กB ID
hyperkalemia, calcium channel blockers toxicity
- B IDFA%!€4E9:$!%&'(?_Y IV; continuous infusion
8&'FJX>:8#I$%D 4 A@>
Neonates: 200 t 800 mg/kg/day
Infant  Children :
200 t 500 mg/ kg/ day
Adults : 2 - 15 g/ 24 hr
- Hypocalcemia tetany
Neonates 100 t 200 mg/ kg/ dose ' L? 9(#IE
500 mg/ kg/ day FJX>:8#I$%D 4 A@>
Infants  Children :
100 t 200 mg/ kg/ dose ( 0.5 - 0.7 mEq/ dose) :8#
$ $9 กกIX 5 t 10 $ 34 ' L:8#€@Y G(#3\ก 6 t 8 ;9.
8&':8# infusion 500 mg/ kg/ day
Adults : 1 t 3 g ( 4.5 t16 mEq )
- Calcium channel blockers toxicity, magnesium
intoxication, cardiac arrest 34_94B ID hyperkalemia 
ก
ก : 100 mg/ kg/ dose 
: 500 t 800 mg/ kg/ dose
Max. : 3 g/ dose   

!  

" #/ $

-

!L&'L >(#IE NSS "Y 8J
pediatric F%D neonate
LY !Hn$?#'>!L&'L >:8#94AI 9
!)#9)#$"N>"\(G9X!ก=$ 50 mg/ ml 

:
- Direct IV ' L:8#K(EG9X?#'>
!L&'L >K(E94'? !MI)'>ก :8#E
0.5 t 2 ml/ min (200 mg/ min)
- Intermittent infusion '? !MI)'>ก 
:8#E G9XAI!ก=$ 200 mg/ min
- Continuous infusion K(E:8#
" %D% E34_!L&'L >F%#I 1000 ml :$
!I% 12 t 24 ;9. '? !MI)'>ก :8#
E G9XAI!ก=$ 200 mg/ min
Pediatric  Neonate :
- Direct IV K(E'? !MI)'>ก :8#E
"N>"\(!3X กJ 50 t 100 mg/ min
- Infusion AI:8#'EX >;# ] F%D
?=(? 9bN#HpIE'EX >?X'!$&_'> K(E'? !MI
"N>"\()'>ก :8#E !3X กJ 120 t 240
mg/ kg :$!I% 9 กกIX 1 ;9. 8&' 0.6
t 1.2 mEq Calcium/ kg :$!I%
9 กกIX 1 ;9.

- G9XAI:8#E FJJ SC F%D IM !$&_'>L กLD3Y :8#
!ก=( tissue necrosis
- y# :8#!MILD3Y :8#!ก=( Vasodilation, %(D(J
AI 9($K%8=?, cardiac arrhythmias, syncope,
cardiac arrest
- y# D(J)'>FA%!€4E9:$!%&'(9 กกIX 12 mg/
dL :8# NSS, IV fluid F%D Furosemide !f&_')J
FA%!€4E9''กF%D?=(? 9I(D(J)'> Potassium
F%D Magnesium I93@>3Y ECG !f&_'?=(? 9ก 
!ก=(B IDF3ก€#'$
- y# !ก=(B ID hypocalcemia LD3Y :8#!ก=(
ก%# 9!$&@'กD?\กF%D!กM> y# !ก=(B ID
hypercalcemia LD3Y :8#!ก=( bradycardia ก(ก 
3Y > $)'>DJJHD" 3 arrhythmias F%Dก 
3Y > $)'>G?JกfX'>
- AI:;#!)M9)$ (!%MกF%D:8#3 > large vein !f&_'%(
ก !ก=(DA E!A&'>
ก  ! : AI 9($K%8=? 8 กbN#HpIEN#"~กHI(
J=!Im34_}4(:8#8E\(E 8&'%(AI 9!MI)'>ก :8#E
%>
- " %D% E34_!L&'L >F%#I94AI 9A>?I 24 ;9.
34_'\m8BN9=8#'>
กกE$กA : '\m8BN9= 15 t 30 °C

Direct IV, IV Infusion

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Cefazolin
(Cefaben)
1g

Cefeplme
(Maxipime)
1g 

/    

/ 
- Antibiotic (Cephalosporins 1st generation )

ก > 1 
: 25 t 100 mg/ kg/ day FJX>:8#3\ก
6 t 8 ;9. )$ ("N>"\(G9X!ก=$ 6 g/ day 
: 250 t 2000 mg :8#3\ก 6 t 12 ;9. (Hก?=
:8# 8 ;9. ) )$ ("N>"\(G9X!ก=$ 12 g/ day
Deep IM, Direct IV, Infusion
- Antibiotic (Cephalosporins 4th generation)

ก :
- Febrile neutropenia : IV; 50 mg/ kg :8#3\ก 8
;9. $ $ 7 t 10 I$
- Uncomplicated skin/ soft tissue infection,
pneumonia, complicated/ uncomplicated UTI :
IV; 50 mg/ kg :8#I$%D 2 A@> 
:
- Most infection: IV; 1 t 2 g :8#3\ก 12 ;9. $ $ 7
t 10 I$ (' L:8#)$ ("N>กIX $4@:$bN#34_?=(!;&@'
pseudomonas)
- UTI : IM, IV; 500 t 1000 mg :8#3\ก 12 ;9.
- Febrile neutropenia : IV; 2 g :8#3\ก 8 ;9. $ $ 7
I$ 8&'L$กIX ' ก LD(4)~@$
Direct IV, IM   

! 

NSS, D5W, D10W, - IM : %D% EE 1 g :$$@Y ก%_$ - Direct IV : 3 - 5 $ 34
D5S/2, D5S,
2.5 ml
- Infusion : 30 - 60 $ 34
RINGER
- Direct IV : %D% EE 1 g :$
$@Y ก%_$ 7.5 - 10.5 ml
- Infusion : %D% E :$
" %D% E34_:;#G(#'EX >$#'E
50 - 100 ml
NSS, D5W, D10W, - IM : %D% E(#IE" %D% E34_ IV Infusion :$ 30 $ 34
SWFI, RINGER
:;#G(# 2.4 ml
- IV : !L&'L >:8#94AI 9!)#9)#$
100 mg/ ml 

" #/ $
- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> F%DA>?I 7 I$
:$?N#!EM$
- D9(DI>ก :;#:$A$G)#G?G9X(4 DI>ก !ก=( anaphylaxis 
D8IX > first dose
- 8# 9b"9I9กJ aminoglycoside
- USFDA Preg Cat B
- 8%>!L&'L >F%#I!กMJ:$?N#!EM$G(# 7 I$F%D
24 ;9. 34_'\m8BN9=8#'>
- DI>ก !ก=( anaphylaxis :$ก :8#E A@>Fก

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Cefoxitin
(Cefoxin) 1 g

Cefotaxime
(Claforan) 1 g 

/    

/   

!  

NSS, D5W, - Direct IV : 1 g :$$@Y ก%_$
D10W,
8&'" %D% E34_:;#G(# 10 ml
RINGER
- Infusion : :$" %D% E34_:;#
G(#'EX >$#'E 50 - 100 ml

- Antibiotic (Cephalosporins 3rd generation) 
ก > 3 

ก : IM, IV;
- Mild t moderate infection : 80 t 100 mg/ kg/ day FJX>
:8#3\ก 4 t 6 ;9.
- Severe infection : 100 t 160 mg/ kg/ day FJX>:8#3\ก 4
t 6 ;9. )$ ("N>"\(G9X!ก=$ 1.2 g/ day
- Preioperative prophylaxis : 30 t 40 mg/ kg :8#กX'$
bX ?($ $ 30 t 60 $ 34 ? 9(#IE 30 t 40 mg/ dose 3\ก 6
;9. :8#G9X!ก=$ 24 ;9. 8%>bX ?( 
: IM, IV; 1 t 2 g :8#3\ก 6 t 8 ;9. )$ ("N>"\(G9X!ก=$
12 g/ day
Direct IV, Infusion IV, IM (!$กK)
- Antibiotic (Cephalosporins 3rd generation )
D5W, NSS 
ก 
ก < 12  456ก < 50 kg:
- ?=(!;&@'3_IGH 50 t 180 mg/ kg/ day FJX>:8#3\ก 4 t 6 ;9.
- Meningitis : 200 mg/ kg/ day FJX>:8#3\ก 6 ;9.
- Uncomplicated infection : IM, IV; 1 g 3\ก 12 ;9.
- Moderate & severe infection: IM, IV; 1 t 2 g 3\ก 8 ;9
- Septicemia : IV; 2 g 3\ก 6 t 8 ;9. 
: IM, IV; 1 t 2 g 3\ก 6 - 8 ;9. )$ ("N>"\(G9X!ก=$ 12
g/ day
Direct IV, Intermittent IV Infusion

%D% Eb>E 1 g (#IE$@Y ก%_$
'EX >$#'E 10 ml F%#I
!L&'L >?X' (#IE" %D% E
34_:;#G(# 

- Direct IV : 3 - 5 $ 34
- Infusion : 15 - 30 $ 34

- Direct IV : 3 - 5 $ 34
- Infusion : 30 - 60 $ 34 

" #/ $
- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> F%D 7 I$
:$?N#!EM$
- DI>ก !ก=( anaphylaxis :$ก :8#E A@>Fก F%D
ก :;#XI9กJE 34_94f=?X'G?F%D:$bN#HpIEKAG?

- USFDA Preg Cat B
- 8%>%D% EF%#IA>?I 12 ;9. 34_'\m8BN9=8#'>F%D
5 I$:$?N#!EM$
- 8 ก:8# IM AIb"9 1 % lignocaine solution !f&_'J!3
' ก HI()mD}4(

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Ceftazidime
(Fortum)
1g

Ceftriaxone
(Rocephin)
1g 

/    

/ 
- Antibiotic (Cephalosporins 3rd generation) 
ก 
ก < 12  : IV; 30 t 50 mg/ kg/
dose :8#3\ก 8 ;9. )$ ("N>"\(G9X!ก=$ 6 g/ day 
: IM, IV; 500 t 2000 mg 3\ก 12 ;9.
IM, Direct IV, IV Infusion
- Antibiotic (Cephalosporins 3rd generation)
- )$ (ก :8#E 1 - 2 g 3\ก 24 ;9.
- Meningitis :8#E 2 g 3\ก 12 ;9.
IM, Infusion
- Antibiotic (Quinolones)

Ciprofloxacin
(Ciprobay, cifloxin)
IV Infusion
400mg, 200 mg
Chloramphenicol
- Antibiotic (anaerobic)
- )$ (ก :8#E 50 - 100 mg/ kg/ day
FJX>:8#3\ก 6 ;9. )$ ("N>"\(G9X!ก=$ 4 g/ day

Chlorpheniramine
Inj. 10 mg/ml

Direct IV, IV Infusion
- antihistamine 10 - 20 mg
bN#:8<X : 5 - 40 mg (IV injection AI:;#!I% }4($ $
กIX 1 $ 34) )$ ("N>"\(G9X!ก=$ 40 mg/ day
!(Mก : 0.0875 mg/ kg 3\ก 6 ;9.
SC, IM, IV (slowly !I% 1 $ 34)   

!

NSS, D5W, D10W
,D5S/2 ,D5S/4
,D5S

- IM : 1 g :$$@Y ก%_$ 3 ml
- Direct IV : 1 g :$$@Y ก%_$
10 ml
- Infusion : :$" %D% E34_
:;#G(#'EX >$#'E 50 - 100 ml
D5W, D10W, NSS, - IM : 1 g :$$@Y ก%_$8&'
D5/NSS, D10/NSS " %D% E34_:;#G(#'EX >$#'E
9.6 ml
- Infusion : :$" %D% E34_
:;#G(#'EX >$#'E 50 - 100 ml
NSS, RINGER ,
!L&'L >:8#94AI 9!)#9)#$
D5W, D10W
1 - 2 mg/ml
D5W, D10W,
D5S/2, D5S/4,
RINGER

-

- Direct IV : 1 g :$$@Y ก%_$
10 ml
- Infusion : :$" %D% E34_
:;#G(#'EX >$#'E 50 - 100 ml
G9X?#'>!L&'L > 

- Direct IV : 3 - 5 $ 34
- Infusion : 30 - 60 $ 34

- Infusion: 30 - 60 $ 34
- IV bolus: %D% EE 1 g
:$ SWFI 10 ml }4($ $
2 t 4 $ 34
IV Infusion ;# ] B E:$
60 $ 34
- Direct IV : 1 $ 34
- Infusion : 30 - 60 $ 34 

! IM
+ ,
-%  . ! ID
/ 0 100mg/ mL 
!
Intravenous 

" #/ $
- 8%>%D% EF%#IA>?I 24 ;9.34_'\m8BN9=8#'> F%D 4 I$:$?N#
!EM$
- ">!ก? phelebitis F%D!H%4_E$ IV site 3\ก 48 - 72 ;9.
- USFDA Preg Cat B
- 8%>!L&'L >F%#IA>?I 24 ;9. 34_'\m8BN9=8#'>F%D
10 I$:$?N#!EM$
- ">!ก? phelebitis F%D!H%4_E$ IV site 3\ก 48 - 72 ;9.
- USFDA Preg Cat B
- 8%>!L&'L >E !กMJ:$?N#!EM$F%D34_'\m8BN9=8#'> (25 '>a )
G(#$ $ 2 "H( 8C
- USFDA Preg Cat C
- 8%>!L&'L >F%#IA>?I 30 I$ 34_'\m8BN9=8#'> F%D 6 "H( 8C
:$?N#!EM$
- AIHJ)$ (:$bN#HpIEKA?JG?
- AI?IL CBC, LFT, Kidney function test
- USFDA Preg Cat C

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Cyclophosphamide
1g

Cyclosporine
(Sandimmune
Inj. 50 mg/ ml (5ml)

Dexamethasone
4 mg/ ml 

/    

/ 
- Antineoplastic Agent, Alkylating Agent

ก:
- SLE : IV; 500 t 750 mg/ m2 3\ก!(&'$ )$ (
"N>"\(G9X!ก=$ 1 g/ m2
- JRA/ Vasculitis : IV; 10 mg/ kg 3\ก 2 "H( 8C

ก   : IV; 400 t 1800 mg/ m2 (30 t
50 mg/ kg) ?X'ก ก :$ 1 A'C" (1 - 5 I$)
" 9 y:8#€@Y G(#:$DED!I% 2 - 4 "H( 8C
IV Infusion, Intermittent IV   

!

NSS

%D% Eb>E 1 g :$" %D% E
34_:;#G(# 50 ml

- Immunosuppressant agent
D5W, NSS
- )$ (ก :8#E 5 - 6 mg/ kg
(0.9%NaCL)
Single dose 4 - 12 ;9. :8#8$~_>I$กX'$ก !H%4_E$
'IEID
IV Infusion
- Coticosteroid, Antinflammatory
NSS, D5W

IM, Direct IV, IV Infusion
Diclofenac
(Voltaren)
75 mg/ 3 ml
Dimenhydrinat
(Divomit)
50 mg/ 2 ml

- Analgesic, NSAIDs
- )$ (ก :8#E 50 - 150 mg / day
IM
- Antiemetics
- )$ (ก :8#E 50 - 100 mg 3\ก 4 ;9
IM, Direct IV

-

D5W, NSS,
RINGER

- IV Infusion b"9E 1 ml
(50mg) :$ 20 - 100 ml )'>
D5W 8&' NSS
8%>b"9G9X?#'>ก$F"> 

IV Infusion : 20 - 30
$ 34

-% ! IV

single dose 4 - 12 ;9
กX'$ก 
transplantation 8$~_>I$
L$กD3_>:8#E 
JHD3 $G(#
< 20 mg : > 1 - 3 $ 34
> 20 mg : 7.5 $ 34
Infusion : :8#? 9Ff3EC
"_>

G9X?#'>!L&'L >

-

- IM, Direct IV : G9X?#'>!L&'L >
- Infusion : !L&'L >:$
" %D% E34_:;#G(# 50 t 100 ml

- Direct IV : %D% EE 50 mg
:$" %D% E34_:;#G(# 10 ml

B E:$ 2 $ 34 

" #/ $
- 8%>b"9E F%#I:8#:;#B E:$ 24 ;9.
- 8 ก!กMJE :$?N#!EM$LD94' E\ 6 I$8%>L กI$34_b"9
- AIHJ)$ (E :$bN#HpIEKA?JF%DG?
- :;#E 'EX >D9(DI>:$bN#HpIE bone marrow suppresion

- USFDA Preg Cat D
- 8# 9F;X!EM$ !กMJ:8#f#$F">
- E }4(8%>b"934_'\m8BN9= 25 '>a !กMJ:$y\>f% "?=ก PVC
G(#$ $ 6 ;9. !กMJ:$B ;$DFก#IG(#$ $ 24 ;9.
- IV dose = 1/ 3 PO dose
- USFDA Preg Cat C
- 8%>L ก!L&'L >F%#I:;#B E:$ 24 ;9. F%D!กMJ:$?N#!EM$G(# 2
I$
- $=E9:8#3 > IM :$NHFJJ)'> Acetate injection
- USFDA Preg Cat C, Din 1st trimester
- F$D$Y :8#3 >ก%# 9!$&@'"DKfก%~ก]
- USFDA Preg Cat B:D in 3rd Trimester or near delivery
- A>?I 10 I$34_'\m8BN9=8#'>

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Dihydralazine
injection 

/    

/ 
- ก B IDAI 9($K%8=?"N>34_\$F>

Direct IV, IV Infusion   

!  

" #/7$

NSS, SWFI

- Direct IV $Y b>E %D% E(#IE$@Y ก%_$34_
G(#9 กJE LY $I$ 2 ml
-IV Infusion ?#'>$Y 9 !L&'L >?X'K(E$Y
25 mg 9 !L&'L >(#IE NSS !3X $@$ 8# 9
b"9กJก%NKA"!$&_'>L ก?IE LD"% E?I
'EX >I(!MI

- Direct IV :8# 6.25 mg
}4(;# ] 'EX >$#'E 2 $ 34
y# LY !Hn$?#'>:8#€@Y AI!I#$ 
DED$ $ 20 t 30 $ 34
กX'$ AII(AI 9($K%8=?
F%D'? ก !?#$)'>8I:L
?%'(!I%
- IV Infusion )$ (E 34_:;#
A&' 25 mg

- 8%>L ก%D% EE F%#IAI:;#3$34 8# 9F;X!EM$!$&_'>L กE
LD?ก?Dก'$ 
7$
- ก }4(E AI:8#(#IEAI 9D9(DI>F%D:8#'ENX:$AI 9(NF%
)'>Ff3EC'EX >:ก%#;=( (y# !Hn$GHG(#:8#bN#HpIE$'$
K>fE J %)
- DI>ก !ก=( postural hypotension 8%>ก :8#E
ก  ! : AIIAI 9($K%8=?F%D'? ก !?#$)'>8I:L
?%'(!I% 
ก overdose : AI 9($K%8=??_Y 8I:L!?#$b=(L>8ID
shock
ก !กMJก : '\m8BN9=D8IX > 15 t 30 °C
- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Diazepam
(Valium)
10 mg/ 2ml 

/    

/ 
- Benzodiazepine, :;#:$B ID anxiety

disorders, panic disorders :;#!Hn$E ">J 
D>JHD" 3 E D>J;ก :;#:$ alcohol
withdrawal symptoms

ก : - "Y 8J">JD>J8&'A% Eก%# 9!$&@'
8&'A% Eก>I% : IM, IV : 0.04 t 0.3 mg/ kg/
dose 3\ก 2 t 4 ;9. L$G(#)$ (E "N>"\(
0.6 mg/ kg B E:$ 8 ;9.
- Status Epilepticus : 3 ก' E\ 30 I$ t 5 H|
IV : 0.05 t 0.3 mg/ kg/ dose :8#E $ $กIX 3
$ 34 :8#€@Y G(#'4ก3\ก 15 t 30 $ 34 )$ ("N>"\(
G9X!ก=$ 5 mg
!(Mก9 กกIX 5 H| IV : 0.05 t 0.3 mg/ kg/
dose :8#E $ $กIX 3 $ 34 :8#€@Y G(#'4ก3\ก 15
t 30 $ 34 )$ ("N>"\(G9X!ก=$ 10 mg 
: - "Y 8J">JD>J8&'A% Eก%# 9!$&@'
8&'A% Eก>I% : IM, IV : 2 t 10 mg 3\ก 3 t 4
;9. y# LY !Hn$
- Status Epilepticus : IV : 5 t 10 mg 3\ก 10
t 20 $ 34 )$ ("N>"\(G9X!ก=$ 30 mg B E:$ 8
;9. :8#E €@Y G(#B E:$ 2 t 4 ;9. y# LY !Hn$
IM, Direct IV, IV Infusion   

!  

" #/ $

NSS, D5W

- IM, Direct IV G9X?#'>!L&'L >
(G9XAIb"9กJ" %D% E'&_$
!$&_'>L กG9X!)# ก$ F?X' L
!?4E9K(Eb"9:$ NSS :$
AI 9!)#9)#$G9X!ก=$ 10 mg/
100 ml y# AI 9!)#9)#$"N>LD
?ก?Dก'$F%Db"9:$)I(Fก#I
!3X $@$ G9XAIb"9:$ plastic
bags 8&' tubing G9XAI:;#
polyvinyl chloride (PVC)
plastics set $'กL ก$4@ก !L&'
L >LD3Y :8#E "N<!"4E
potency G(#!MI)

- IM
- Direct IV :$bN#:8<XLD:8#:$
'? !MIG9X!ก=$ 5 mg/ min
:$!(Mก 1 t 2 mg/ min y# :8#
3 >" E:8#" $@Y ?#'>:8#?>
?Y F8$X>:ก%#!)M934_?X':8#
bN#HpIE9 ก34_"\( !$&_'>L ก' L
!ก=(HŠ=ก==E กJ" E:8#" $@Y
G(#F%D8%>L ก:8#E F%#IAI
flush (#IE NSS (2 - 5 mg/
$ 34 y# :8#!MI3Y :8#!ก=(
apnea hypotension,
bradycardia 8&' cadiac
arrest )

- )$ (:8#F?X%DA@>G9XAI!ก=$ 30 mg
- 8# 9b"9I9กJE '&_$] !f DLD3Y :8#?ก?Dก'$
- !L&'L > 1: 40 v/ v LD94AI 9A>?I 6 ;9.
- y# !L&'L > > 1: 50 A>?I 24 ;9.
- G9X$=E9:8# Infusion !$&_'>L ก' L!ก=(ก ?ก?Dก'$F%Dก 
(N(€JE L กy\>E G(#
ก  ! : ?=(? 9I(D(JAI 9($กX'$, D8IX >F%D8%>
ก :8#E , ก !ก=(8%'(!%&'((Y 'ก!"J:$?Y F8$X>34_:8#E
กX'$:8#E AII('? ก 8 E:Ly# ?_Y กIX 12 A@>?X'$ 34 AI
FL#>:8#Ff3EC3 J 8%>ก :8#E 1 ;_IK9>AI?=(? 9I('?
ก 8 E:L y# 8 กG(#$#'EกIX 8 A@>?X'$ 34:8#H%\กbN#HpIE:8#94
'? ก 8 E:L!Hn$ 10 t 12 A@>?X'$ 34 y# G9X" 9 y3Y G(#
:8#;XIE8 E:L F%DFL#>:8#Ff3EC3 J 
ก@A : CNS depression, respiratory depression 94
' ก "J"$ coma AI 9($K%8=??_Y fN(;#
- G9X:;#:$bN#HpIE Narrow angle glaucoma
- G9X:;#E NHFJJJHD3 $:$!(Mก' E\$#'EกIX 6 !(&'$
- G9X:;#E NHFJJ}4(:$!(Mก' E\$#'EกIX 30 I$
- G9X:;#:$"?494ABC

- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Digoxin (Lanoxin)
0.5 mg/ 2 ml 

/    

/ 

- Antiarrthymic agent, ก B ID
Congestive heart failure F%D:;#!f&_'%(
'? ก !?#$)'>8I:L8#'>%X >:$B ID
atrial fibrillation, atrial flutter F%D
supraventricular tachycardia,
cardiogenic shock
Daily dose* (µg/ kg)
Initial
Maintenance
Preterm infant
15 t 20
4t6
Full-term infant
20 t 30
6t8
1 !(&'$ t 2 H|
30 t 50
7.5 t 12
2 t 5 H|
25 t 35
8t9
5 t 10 H|
15 t 30
4t8
> 10 H|
8 t 12
2t3
bN#:8<X
500 t 1,000
100 t 400
* :$!(Mก' E\$#'EกIX 10 H| FJX>:8#3\ก 12 ;_IK9> 
M   

!

D5W, NSS, D10W, - G9X?#'>!L&'L >8&'!L&'L >E
SWFI
1 ml :$$@Y ก%_$8&'" %D% E
34_:;#G(#H=9 m 4 ml  

" #/ $

- 'EX >$#'E 5 $ 34 :8#bX $
3 - way 8&' Y - site

- !9&_'!L&'L >F%#IAI:;#3$34
- :;#" %D% E!ก=$ 4 !3X ?IE LD?ก?Dก'$
- !กMJ34_'\m8BN9=G9X!ก=$ 25 '>a Hl'>ก$F">
- ก :8#E !)# 8%'(!%&'((Y 'EX >I(!MI!Hn$" !8?\:8#!ก=(ก 
8(?I)'>8%'(!%&'( $Y GH"NXB IDAI 9($K%8=?"N>G(# F%D/
8&'%(ก G8%!I4E$)'>!%&'(:$!"#$!%&'(KAK$ 4_ ก }4(E
'EX >;# ] L~>!Hn$"=_>"Y A<:$bN#HpIE34_!ก=( hypertensive heart
failure F%D acute myocardial infarction
- :$bN#HpIE34_!Hn$KA!ก4_EIกJ?X'9‚E'E(C?#'>:8#'EX > 

D9(DI> AI%()$ (E !=_9?#$F%D)$ (?X'!$&_'>!9&_'
?X'9‚E'E(C3Y > $?_Y กIX Hก?= :$bN#HpIE34_94
hyperthyroidism fJIX LD(&@'?X' digoxin ' L?#'>!f=9_
)$ (E )~@$D8IX >:8#ก ก f=)'>‚E'E(C
(thyrotoxicosis) AI%()$ (E %>!9&_'" 9 yAIJA\9B ID
f=(>ก%X IG(#F%#I
ก  ! : กX'$:8#E F?X%DA@>:8#?=(? 9I(;4fL!Hn$!I%
1 $ 34 F%Dy# fJIX 94ก !H%4_E$FH%> !;X$ !?#$G9X!Hn$L>8ID
Hก?=8&''? ก !?#$)'>8I:L?_Y กIX 60 A@>?X'$ 348&'
9 กกIX 100 A@>?X'$ 34 !Hn$?#$ €~_>y# '? ก !?#$)'>8I:L
?_Y กIX 60 A@>?X'$ 34LDJX>;4@IX !ก=(f=L กE , BP, :$D8IX >
:8#E AI3Y ECG 'EX >?X'!$&_'> !f&_'?=(? 9ก !ก=(
arrythmias €~_>y# !ก=(LDJX>J'กIX !ก=(f=L กE

Direct IV, IM (9กHI( G9XAX'E:;#)

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

!  

" #/ $

Dobutamine
(Dobutrex)
250 mg/ 20
ml

- Sympathomimetic agents, :;#!f=_9
cardiac output DED"@$:$bN#HpIE34_94B ID
cardiac decompensate 34_94" !8?\L ก
KA8I:L, 8%>ก bX ?(8I:L8&' acute
myocardial infarction
- )$ (ก :8#E :
Neonate : 2 t 15 µg/ kg/ min
Children & Adult : 2.5 t 20 µg/ kg/ min
HJ)$ (E L$G(#b%? 9?#'>ก  K(E)$ (
E "N>"\(G9X!ก=$ 40 µg/ kg/ min :8#E
?=(?X'ก$G9X$ $กIX 72 ;_IK9>

D5W, D5S/2,
D5S, NSS,
RINGER

Dobutamine Lyophilized powder A@>Fก:8#b"9
กJ SWFI 8&' D5W LY $I$ 10 ml !)EX :8#%D% E
8 ก?IE %D% EG9X89(:8#!f=_9!Hn$ 20 ml F%#I!)EX
L$%D% E!Hn$$@Y E :" !9&_'LDJ=8 E :8#bN#HpIE
?#'>!L&'L >(#IE IV Solution :8#G(#AI 9!)#9)#$
"N>"\(!3X กJ 5 mg/ml

- IV Infusion central line
8&' !"#$!%&'((Y :8<X F%D
AI:;# Infusion pump
AI%()$ (E %>;# ]
'EX >"9_Y !"9' F3$ก 
8E\(}4('EX >3$343$:(
!f D' L!ก=( AI 9($
K%8=??_Y 3$343$:(

- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> 
7$ :
- E 94"XI$HDก'J)'> sulfites €~_>' L3Y :8#!ก=( allergic
reaction :$bN#HpIEJ > EG(#
- ' ก 34_!ก=()~@$!9&_')$ (E "N>!ก=$GH !;X$ tachycardia
8&'ก !H%4_E$FH%>)'>AI 9($K%8=?'EX >9 ก (>$@$
y# !ก=(' ก AI%D)$ (E %>8&'8E\(E L$' ก LD
A>34_
ก  !: D(JKHF?"!€4E9:$!%&'(, I(D(JAI 9
($K%8=?F%D'? ก !?#$)'>8I:L'EX >?X'!$&_'> 
ก overdose: 'X'$!f%4E กDI$กDI E 8I:L!?#$
!MI AI 9($K%8=?"N> 8I:L!?#$G9X!Hn$L>8ID

-E
AI
-E
AI
-E
AI

250 mg !L&'L >:$" %D% E 1000 ml G(#
9!)#9)#$ 250 µg/ ml
250 mg !L&'L >:$" %D% E 500 ml G(#
9!)#9)#$ 500 µg/ ml
250 mg !L&'L >:$" %D% E 250 ml G(#
9!)#9)#$ 1000 µg/ ml

" %D% E)'> dobutamine ' L!ก=("4;9fN €~_>LD
!)#9)~@$!&_'E] !9&'_ !I% bX $GH F?XG9X94b%?X'AI 9
F>)'>E 8 ก:;#:$;XI>!I% 34_DJ\GI#

IV Infusion

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Dopamine
250 mg/ 10 ml 

/    

/ 
- Sympathomimetic agents, :;#!f=_9 cardiac
output, blood pressure F%D urine flow !f&_'
;XIEก B ID shock 8%>L กก :8#" $@Y
'EX >f'!f4E>F%#I 
ก : 1 t 20 µg/ kg/ min HJ)$ (E ? 9
ก ?'J"$'>

ก : 1 t 20 µg/ kg/ min HJ)$ (E ? 9ก 
?'J"$'> )$ (E "N>"\( 50 mcg/ kg/ min 
: 1 t 5 L$y~> 20 µg/ kg/ min :$ก 
HJ)$ (E LD!f=_9A@>%D 1 t 4 µg/ kg/ min
3\ก 10 t 30 $ 34L$G(#ก ?'J"$'>34_?#'>ก 
)$ (E "N>"\( 50 µg/ kg/ min
8 ก:;#)$ (E 9 กกIX 20 t 30 mcg/ kg/ min
' L:;# direct-acting pressor !;X$
epinephrine, norepinephrine F3$

Continuous IV Infusion S 
infusion
pump " microdrip set  $8   

!

D5W, D5S/2, D ?#'>!L&'L >E กX'$}4( :;#
5S, NSS, RINGER Dopamine 10 ml b"9
" %D% ELY $I$ 250 ml 8&'
500 ml :$กm4bN#HpIELY ก($@Y
8&' J=8 E 'EX >;# ]
" 9 y%D% EE :8#G(#AI 9
!)#9)#$ 1.6 8&' 3.2 mg/ ml
$@Y E 34_!L&'L >F%#I?#'>:;#:8#
89(B E:$ 24 ;9. Hl'>ก$
F"> $@Y E 34_!L&'L >LD94"4
!8%&'>L >] 8 ก$@Y E 94"4
!H%4_E$GH 8&'"4!)#9)~@$ G9XAI
:;#
(%D% E?IE 200 - 400 mg
:$" %D% E34_:;#G(# 250 500 ml)  

" #/ $

- Shock: :8#!=_9?#$
2 - 5 µg/ kg/ min F%#IHJ
? 9ก ?'J"$'>)'>bN#HpIE
- CHF : :8#!=_9?#$
0.5 - 2 µg/ kg/ min
F%#IHJ? 9ก ?'J"$'>
)'>bN#HpIE

- :8# IV Infusion central line 8&' !"#$!%&'((Y :8<X F%D AI
:;# Infusion pump AI%()$ (E %>;# ] 'EX >"9_Y !"9'
F3$ก 8E\(}4('EX >3$343$:( !f D' L!ก=( AI 9($K%8=?
?_Y 3$343$:(
- E 34_!)# ก$G(# : Dobutamine, epinephrine, isoproterenol,
lidocaine 
7$ : DI>ก _I''ก$'ก!"#$!%&'(!$&_'>L กLD3Y :8#
!ก=( gangrene
- !9&_'LD8E\(E :8#AX'E ] %('? !MI)'>ก :8#E !f&_'Hl'>ก$
ก !ก=( hypotension 'EX >\$F>
- ก :8#E :$)$ ("N>LD!f=_9 renal vasoconstriction F%D
peripheral resistance
- กX'$:8#E dopamine AIHJB ID hypovolumia กX'$
E 94"XI$b"9)'> sulfites ' L3Y :8#!ก=(ก Ff#E G(#
- 8%>%D% EF%#IA>?I 24 ;9. 34_'\m8BN9=8#'> (y# "4!)#9)~@$:8#
3=@>GH)
ก  ! : กX'$F%DD8IX >:8#E AI?=(? 9 heart rate,
blood pressure, urine output, cardiac output, central
venous pressure, peripheral perfusion 
ก overdose : AI 9($K%8=?"N> 8I:L!?#$G9X!Hn$L>8ID
G?I E!}4EJf%$
- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Diphenhydramine
(Benadryl)
50 mg/ ml

Ephedrine sulfate
50 mg/ ml,
10 ml 

/    

/ 
- Antidote, Antihistamine

ก : IM ; 1.25 mg/ kg 8&' 37.5 mg/ m2 )'>
f&@$34_X >ก E :8#I$%D 4 A@> )$ (ก :8#E
"N>"\(G9X!ก=$ 300 mg/ day 
: IM, IV ; 10 t 50 mg )$ (ก :8#E
"N>"\(G9X!ก=$ 100 mg/ dose F%D 400 mg/ day
- ก B ID Dystonic reaction

ก : IM, IV ; 0.5 t 1 mg/ kg/ dose 
: IM, IV ; 10 t 50 mg single dose :8#
€@Y 3\ก 2 t 4 ;9. "N>"\(G9X!ก=$ 400 mg/ day
IM, IV Infusion, Intermittent IV
- Sympathomimetic agents, Alpha t Beta
agonist
- ก B ID Idiopathic orthostatic
hypotension, acute bronchospasm

ก : IM, IV Push ; 0.2 t 0.3 mg/ kg/ dose
3\ก 4 t 6 ;9. 
: IM, SC ; 25 t 50 mg )$ ("N>"\(G9X
!ก=$ 150 mg/ day
IV : 5 t 25 mg/ dose slow IV push €@Y G(#'4ก 5
t 10 $ 34 y# LY !Hn$" 9 y:8#G(#3\ก 3 t 4 ;9.
IM, SC, Direct IV   

!

NSS, D5W, D10W, !L&'L >:$" %D% E34_:;#G(#:$
NSS, RINGER
AI 9!)#9)#$ 100 mg/ L

-

G9X?#'>!L&'L >' L:8#bX $
Y - tube 8&' three way
stopcock 

Direct IV : 25 mg 'EX >$#'E
1 $ 34

- IM, SC, slow IV push G9X
?#'>!L&'L >E กX'$}4( K(E
slow IV push :$bN#:8<X }4(
€@Y 8X >ก$ 5 t 10 $ 34 y#
LY !Hn$ :8#?X'GH3\ก 3 - 4 ;9.
F?XG9X!ก=$ 150 mg/ day
)$ (E :$!(MกG9X!ก=$ 3 mg/
kg/ day 

" #/ $
- ">!ก?' ก Ff#!;X$b&_$A$, %9f=, 8 E:L3$34?=()(,
AI 9($?_Y
- 8# 9:;#:$ New Born F%D Premature infant
- Hl'>ก$F">
(Onset : 20 t 30 $ 34, Duration : 6 t 8 ;9. )

- USFDA Preg Cat B
- 8 ก" %D% E)\X$8&'94?Dก'$G9XAI$Y 9 :;#
- !กMJE 34_'\m8BN9=8#'>:8#f#$F"> 
7$ :
- :8#HJB ID hypovolumia กX'$:8#E
ก  ! : AI 9($K%8=?, ;4fL F%D urine output 
ก overdose : dysrythmias, CNS excitation ก(ก 
8 E:L €~9!a# ' !L4E$ ;กก !ก=( overdose ' L3Y :8#!ก=(
CV collapse :8#Fก#G)? 9' ก 34_!ก=()~@$ G9X94 antidote 34_
LY !f D!L DL>
- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Epoetin Alfa
(Eprex)
2,000 u/ ml, 1 ml
3,000 u/ ml, 1 ml
4,000 u/ ml, 1 ml 

/    

/    

!

- Colony - Stimulating Factor, ก anemia
34_94AI 9"9f$‚CกJก :;# AZT ก HIV
infection, B ID CHF, bN#HpIE34_G(#Jก bX ?(
F%#I94 Allogenic blood transfusion %(%>.
- CHF patient : IV, SC ; )$ (ก :;#E (>:$
?>

-

G9X?#'>!L&'L >

Initial

!(Mก

50 u/ kg
3 times/
week

bN#:8<X

50 t 100
u/ kg
3 times/
week

Maintenance
Dialysis
167 u/ kg/
week 8&'
76 u/ kg
2 t 3 times/
week
75 u/ kg
3 times/
week

No dialysis
50 t 250 u/
kg
1 t 3 times/
week 

Direct IV : 1 $ 34 

" #/ $
- B ;$D single dose (1 ml) A>?I 2 ' 3=?EC
34_'\m8BN9=8#'> (Eก!I#$)$ ( 4000 u/ ml A>?I 1 ' 3=?EC)
- B ;$D multiple dose (2 ml) A>?I 1 ' 3=?EC34_'\m8BN9=8#'>
- DI>ก :;#:$bN#HpIE34_Ff#'%JN9=$ F%DbN#HpIE34_AIJA\9AI 9
($K%8=?:8#'ENX:$D(JHก?=G9XG(# 
7 : AI 9($K%8=?"N>, HI(a4D, A%&_$G"#, G9X94F>,
JI9, !LMJ8$# 'ก, 3#'>!"4E
- AI!กMJE GI#34_'\m8BN9= 2 t 8 '>a !€%!€4E"
- 8# 9!กMJ:$;X'>F;XF)M>
- 8# 9!)EX )I(

75 t 120 u/
kg

- Surgery patient : กX'$:8#?#'>!L D!%&'((N 
D(J HB IX 9 กกIX 10 mg/ dl 8&'$#'EกIX
13 mg/ dl
Adult : SC ; !=_9:8# 300 u/ kg/ day กX'$bX ?(
10 I$, I$34_bX ?( F%D8%>L กbX ?('4ก 4 I$

Direct IV, SC

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

!

- Hl'>ก$F%Dก thromoembolic disorders
Enoxaparin
Hl'>ก$B ID8%'(!%&'((Y ?4J (Venous thromboembolic disease) :$bN#HpIEa%Eก9
injection
60 mg/ 0.6 ml =<  >6
Hip replacement :
- 30 mg I$%D 2 A@> K(E:8#E A@>Fก8%>ก bX ?( 12 t 24 ;9. 8%>L ก$@$:8#E ?X'L$กD3_>bN#HpIEG9X94AI 9!"4_E>?X'ก 
80 mg/ 0.8 ml
!ก=( DVT 8&'!9&_' warfarin :8#b%ก ก K(E!}%4_ELD:8#E $ $HD9 m 7 t 10 I$
- 40 mg I$%DA@> K(E:8#E A@>FกกX'$ก bX ?( 9 t 15 ;9. 8%>L ก$@$:8#E ?X'L$กD3_> bN#HpIEG9X94AI 9!"4_E>?X'ก !ก=( 
890
DVT 8&'!9&_' warfarin :8#b%ก ก 8 กbN#HpIEG9XG(#JE warfarin ' L?#'>:8#E I$%DA@>?X''4ก 3 "H( 8C (I9!Hn$ 4
$/ก
"H( 8C) 
:0 
<= >6
Knee replacement :
$;:0
- 30 mg I$%D 2 A@> K(E:8#E A@>Fก8%>ก bX ?( 12 t 24 ;9. 8%>L ก$@$:8#E ?X'L$กD3_>bN#HpIEG9X94AI 9!"4_E>?X'ก 
!ก=( DVT 8&'!9&_' warfarin :8#b%ก ก K(E!}%4_ELD:8#E $ $HD9 m 7 t 10 I$ maximum course 14 I$
- :$bN#HpIE34_$@Y 8$ก$#'EกIX 45 kg 8&'' E\9 กกIX 65 H| ' L:8#E :$)$ ( 0.5 mg/ kg/ dose 3\ก 12 ;9. !f&_'%(AI 9
!"4_E>ก !ก=(B ID!%&'(''ก 
<= >6 
CDD :
- :8#E )$ ( 40 mg I$%DA@> :8#E A@>FกกX'$ก bX ?( 2 ;9. DED!I% ก :8#E !}%4_E 7 t 10 I$ "N>"\( 12 I$
- ก ก Acute proximal DVT : :8# warfarin B E:$ 72 ;9. F%D:8# enoxaparin XI9ก$L$G(#AX INR 2.0 - 3.0 (HD9 m 7 I$) 
<= DVT HIJHKJJHL= pulmonary embolism : SC 1 mg/ kg/ dose 3\ก 12 ;9. 8&' 1.5 mg/ kg I$%DA@>
- "Y 8JHl'>ก$B ID8I:L) (!%&'(:$bN#HpIE unstable angina 8&' non-Q wave MI : SC : 1 mg/ kg/ dose I$%D 2 A@> K(E:8# 
XI9กJ aspirin 100 t 325 mg/ day :8#'EX >$#'E 2 I$L$bN#HpIE94' ก 3 >A%=$=ก(4)~@$
- ก Hl'>ก$ก !ก=(%=_9!%&'(:$)mD%# >G?(#IE!A&_'>G?!34E9 : :8#E )$ ( 1 mg/ kg 8 กbN#HpIE94AI 9!"4_E>"N>?X'ก !ก=(!%&'(''ก
AI%()$ (E %>!Hn$ 0.5 mg/ kg F%DAI:8#E bX $3 > arterial line :$;XI>?#$)'>กDJI$ก %# >G? HD"=3‚=B f)'>E LD'ENXG(#
$ $ 4 ;9. 'EX >GกM? 98 ก94 fibrin !ก=()~@$ ' L:8#E !f=_9G(#'4ก!Hn$ 0.5 t 1 mg/ kg
O56P <=HIJHL=ก5DQDK>PกRD bN#HpIE34_94 creatinine clearance < 30 ml/ min :8#E )$ ( 1 mg/ kg/ day :8#I$%D
A@>"Y 8Jก 8&' 20 mg/ day "Y 8JHl'>ก$  

" #/ $
- :8#K(Eก }4(!)# :?#b=I8$> 890$/ก  
:0$;:0
- !9&_'94ก 3Y Epidural/ spinal anesthesia XI9กJก :;#
E Enoxaparin ก :"XF%Dก y'( catheter AI3Y !9&_'
3‚=ƒ?# $ก F)M>?I)'>!%&'('ENX:$D(J?_Y F%#I 8&'3Y
8%>L กG(#JE )$ ( 40 mg/ I$ 8&'?_Y กIX GHF%#I 10 t
12 ;9. 8&'8%>L กG(#JE )$ ("N> (1mg/ kg I$%D 2
A@>8&' 1.5 mg/ kg I$%DA@>) GHF%#I 24 ;9. 8 ก
LY !Hn$?#'>:8# enoxaparin '4ก AI3=@>;XI>8X >G9X$#'EกIX 2
;9. 8%>y'( catheter ''ก LY !Hn$?#'>94ก ?=(? 9"B ID
)'>bN#HpIE3 >DJJHD" 3'EX >:ก%#;=( 8 ก">"EIX 94
neuroxial hematoma !ก=()~@$?#'>4JI=$=L}EF%D:8#ก  
ก XI9กJก 3Y spinal cord decompression
- AID9(DI>ก :;#E :$bN#HpIE34_'ENX:$"B ID!"4_E>?X'ก 
!ก=(!%&'(''ก !;X$ bN#HpIE34_94ก F)M>?I)'>!%&'(b=(Hก?=, 94
HDI?=Fb%:$กD!f D' 8 , 94HDI?=!%&'(''ก:$"9'>,
AI 9($K%8=?"N>\$F>G9X" 9 yAIJA\9G(#, KA!J 8I $
34_94' ก  retinopathy !Hn$?#$
ก  ! : ?IL$J!กM(!%&'(, 8 occult blood 8&'
B ID!%&'(''กb=(Hก?='&_$] 8 !กM(!%&'(%(%>?_Y กIX 30 50 % )'>AX !=_9?#$ :8#8E\(E , G9XLY !Hn$?#'>?IL8 AX PT
8&' PTT 
ก overdose : ก 94!%&'(''กb=(Hก?=
- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Estrogen
Conjugated
25 mg/ 5 ml

5 - Fluorouracil
(5 - FU)
250 mg/ 5 ml
Furosemide
(Lasix)
20mg/ 2 ml 

/    

/ 
- Estrogen derivatives
- Abnormal uterine bleeding : IM, IV ; 25 mg y#
LY !Hn$' L:8#€@Y G(#3\ก 6 t 12 ;9.
- Uremic bleeding : IV ; 0.6 mg/ kg/ day !Hn$ 
DED!I% 5 I$
IV, IM
- Antineoplastic agent
- 12 mg/ kg/ day !I% 4 I$? 9(#IE
6 mg/ kg/ day '4ก 4 I$
Direct IV, Intermittent IV
- Diuretic, Loop
- :;#ก B IDJI9L ก CHF, HTN, KA?J F%DG?
Infant & Children : IM, IV ; 1 mg/ kg/ dose !f=_9
)$ (E )~@$G(#A@>%D 1 mg/ kg/ dose :8#E 3\ก 6 t
12 ;9.
Adult : IM, IV ; 20 t 40 mg/ dose :8#E 3\ก 6 t 12
;9. K(E3_IGH"Y 8J Acute pulmonary edema :;#
)$ ( 40 mg IV :8#$ $กIX 2 $ 34 y# G9Xf'
" 9 y!f=_9)$ (E G(#y~> 80 mg
Continuous IV infusion ; !=_9(#IE IV bolus 0.1
mg/ kg ? 9(#IE IV infusion 0.1 mg/ kg/ hr !f=_9
)$ (E G(#'4ก!3X ?I3\ก 2 ;9. )$ ("N>"\(G9X!ก=$
0.4 mg/ kg/ hr
IM. Direct IV, IV infusion  

! 

Sterile diluent, %D% Eb>E :$" %D% E34_:;#G(#
WFI, NSS,
!)EX b"9ก$!J
Dextrose 
$/% <!

NSS, D5W

NSS, D5S,
D5W, D10W ,
RINGER, 3 %
NaCI

- Direct IV : G9X?#'>!L&'L >8&'!L&'
L >" %D% E34_:;#G(# (:8#bX $" E
IV !f&_'%(AI 9!LMJHI()
- Infusion : !L&'L >
- Direct IV, IM : G9X?#'>!L&'L >
- Infusion : !L&'L >(#IE" %D% E
34_:;#G(#  

" #/ $

IV Direct }4(;# ]

- 8 ก}4(3 > IV AI}4(;# ] !f&_'Hl'>ก$ก !ก=( Flushing
- 8# 9:;#:$bN#HpIE34_Ff#E
- :8#bN#HpIEJHD3 $ Vit D F%D Calcium 'EX >!f4E>f'
- 8# 9!)EX )I(E F> y# "4!)#9)~@$:8#3=@>GH
- 8%>!HŽ(AI!กMJ:$?N#!EM$ K(E!กMJG(#G9X!ก=$ 60 I$
- USFDA Preg Cat X
- Direct IV : 1 - 2 $ 34 - !L&'L >F%#IA>?I 24 ;9. 34_'\m8BN9=8#'> b"9E ? 9F$I3 >
- Intermittent IV : 2 - 8 ก !?4E9E !A94JY J(:$ Biohazard laminar flow 34_G(#
;9. y# :8#!MILD3Y :8#!ก=( 9 ? $!f D' L!ก=('$? EกJbN#!?4E9E G(#
f=
- USFDA Preg Cat X
- Direct IV : 20 mg/ 1 - - !9&_'!L&'L >F%#IAI:;#B E:$ 24 ;9. 8 ก" %D% Eก% E
2 $ 34
!Hn$"4!8%&'>:8#3=@>3$34
- IV Infusion : G9X
- y# :"X?N#!EM$LD?ก?Dก'$ 3=@>GI#34_'\m8BN9=8#'>F%#I" 9 y$Y
9 กกIX 4 mg/ $ 34
ก%J9 :;#G(#'4ก
)$ (E !f=_9!?=9:
- Refractory HF : IV ; 8 g/ day
- Elderly : IM, IV ; 20 mg/ day

- USFDA Preg Cat C,D if used in preg induced
hypertension

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Fentanyl injection
0.05 mg/ ml 

/    

/ 
- :;#!Hn$E ">JD>JHD" 3กX'$ก bX ?(8&'3Y
8?yก )$ (!%Mก, :;#D>JHI(

ก 1  12  :
- :;#">JHD" 3:$ก 3Y 8?yก )$ (!%Mก/
J!3 HI( : IM, IV : 1 t 2 µg/ kg/ dose ' L:8#
€@Y G(#:$DED!I% 30 t 60 $ 34 !(Mก' E\ 18 t 36
!(&'$ ' L:;# 2 t 3 mg/ kg/ dose
- A>"B f">JHD" 3 : !=_9 IV bolus : 1 t 2 µg/
kg F%#I:8# 1 t 3 µg/ kg/ hr L$G(#)$ ("N>"\(A&' 5
µg/ kg/ hr

กJกก= 12    :
- :;#">JHD" 3:$ก 3Y 8?yก )$ (!%Mก/
J!3 HI( : IV : 25 t 50 µg :8#E €@Y G(#3\ก 3 t 5
$ 34L$G(#ก ?'J"$'>34_?#'>ก  )$ (E "N>"\(G9X
!ก=$ 500 µg/ 4 hr
- :;#">JHD" 3กX'$ก bX ?( 8&':;#XI9กJE ;
!}f D34_8&'J!3 ' ก HI(8%>bX ?( : IM,
Slow IV : 25 t 100 µg/ dose กX'$bX ?( 30 $ 34
- :;#XI9กJE ; 3_IGH : Slow IV :
Low dose : 0.5 t 2 µg/ kg/ hr
Moderate dose : !=_9?#$ 2 t 15 µg/ kg/ dose :8#
?X':$)$ ( 1 t 2 µg/ kg/ hr
High dose (rare use) : 20 t 50 µg/ kg/ hr
IM, Direct IV, IV Infusion  

!  

SWFI, NSS, - IM G9X?#'>!L&'L >
D5W
E
- Direct IV: y# :8#
K(EI="<<4Ff3EC
' LG9X?#'>!L&'L >
E 8&'' L!L&'L >
(#IE sterile water
8&' NSS 'EX >
$#'E 5 ml
- Continuous IV
Infusion : !L&'L >
E (#IE 250 ml
)'> D5W  

" #/ $

- IM
- Direct IV : :$bN#:8<X:8#" %D% E34_!L&'L >
F%#I 0.1 mg :8#!I% 1 t 2 $ 34
y# )$ (E "N> (> 5 mcg/ kg) ' L:;#!I%
5 t 10 $ 34
ก :;#:$!(Mก:;#)$ ( 1 t 2 mcg/ kg/ dose
K(E:;#!I% :8#E $ $ 3 t 5 $ 34
- Continuous IV infusion : J >A@>LD:;#;ก
$Y ก "%JF%DD>J' ก HI( '? !MI)'>
ก :8#E LDHJ? 9)$ (E 34_?#'>ก F%D
ก ?'J"$'>)'>bN#HpIE
!(Mก' E\D8IX > 1 t 12 H| LD!=_9:8#:$'? !MI
1 mcg/ kg/ hr F%DHJ)$ (E L$G(#b%? 934_
?#'>ก K(E)$ (E "N>"\(!3X กJ 3 mcg/ kg/
hr
!(Mก' E\$#'EกIX 1 H| !=_9:8#:$'? !MI
0.5 t 1 mcg/ kg/ hr

- y# :8#:$'? 34_;# !ก=$GH' L3Y :8#!ก=(!f#'A%_> กDI$
กDI EXI9กJ94 laryngospasm y# :8#:$'? 34_!MI!ก=$GH
LD3Y :8#!ก=(ก !กM>?I)'> chest wall F%Dก%# 9!$&@'% E
3Y :8#EJE@>ก F%ก!H%4_E$''ก€=!L$94b%3Y :8#!ก=(ก 8E\(
8 E:LG(#
กกE$กA : Hl'>ก$F"> '\m8BN9= 15 t 30 °C
- !9&_':;#E :$)$ ("N>LD94b%ก(ก 8 E:L$ $!Hn$!I%
8% E;9. 8%>‘’“$L กก "%JG(# 8 ก!ก=(B ID$4@AI
;XIE!8%&'ก 8 E:L
- :$bN#HpIE34_G(#J)$ (E €@Y 8&'94B ID(&@'?X'E ก%\X9
opioids ' L!ก=(ก (&@'?X' fentanyl G(#
- E ' L3Y :8#!ก=(ก !กM>?I)'> chest wall 94b%EJE@>ก 
F%ก!H%4_E$''ก€=!L$"X>b%?X'DJJ8 E:L €~_>' L!ก=(G(#
L กก ;ก$Y ก "%J
- 8%>L กbN#HpIE‘’“$L กก "%J' LLD!ก=( delayed
respiratory depression, respiratory arrest, bradycardia,
asystole arrythmias F%D hypotension
y# !ก=(B ID Overdose AI:8#ก ก FJJ supportive
L$กIX E LDyNก metabolized 89( (half life 2 - 4 ;9.)
- ก  reverse B ID respiratory depression AI:8#
naloxone 2 mg IV (0.01 mg/ kg :$!(Mก) :8#€@Y G(#L$G(#
)$ (E I9G9X!ก=$ 10 mg
- USFDA Preg Cat C; D if prolonged use/high doses at
term 

กกUV:
- IM; onset 7 t 15 $ 34 DED!I% 1 - 2 ;9.
- IV; onset 3$34 DED!I% 0.5 - 1 ;9.

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Gentamicin
80 mg/ 2 ml

Haloperidol lactate
(Haldol)
5 mg/ ml, 1 ml

Haloperidol
Decanoate
(Haldol decanoas)
50 mg/ml, 1 ml 

/    

/   

- Antibiotic, Aminoglycoside
- )$ (ก :8#E : IM, IV ; 2 t 2.5 mg/ kg/ dose
3\ก 8 t 12 ;9.
- Hl'>ก$ bacterial endocarditis : 1.5 mg/ kg
(max 80 mg) XI9กJ Ampicillin 50 mg/ kg (max
2 g) กX'$3Y 8?yก  30 $ 34
IM,IV Infusion
- Antipsychotic agent, sedative
-
ก 6  12  : IM ; 1 t 3 mg/ dose 3\ก 4 t
8 ;9. )$ ("N>"\(G9X!ก=$ 0.15 mg/ kg/ day
-  : Psychosis: IM ; 2 t 5 mg 3\ก 4 t 8 ;9.
IM, Direct IV, IV Infusion
- bN#:8<X : Psychosis : 50 t 100 mg 3\ก 4 "H( 8C

NSS, D5W,
RINGER

- Infusion : 1 amp :$
" %D% E34_:;#G(#'EX >$#
'E
50 - 200 ml

NSS, D5W

- Direct IV : G9X?#'>!L&'L > - Direct IV : 5 mg/ $ 34
- Infusion : !L&'L >?X':$ - IV Infusion : 'EX >$#'E
" %D% E34_:;#G(#
30 $ 34

IM $ % &

- 

!

-  

" #/ $

1 .5 - 2 ;9. !f&_'3Y :8#E 94
3‚=ƒ:$ก ”X !;&@'E I)~@$

- 8%>b"9!f&_':8# IV Infusion F%#I AI:;#B E:$ 24 ;9.
- E 8%>!HŽ(:;#F%#I94AI 9A>?I 30 I$
- G9XF$D$Y :8#!กMJ:$?N#!EM$
- ก :8#!MI!ก=$GH:$)$ ( > 100 mg LD3Y :8# hearing loss
G(#
- AI:8#E HŠ=;4I$D'&_$8%> genta 'EX >$#'E 1 ;9.
- USFDA Preg Cat C
- !9&_'!L&'L >F%#IA>?I 24 ;9. 34_'\m8BN9=8#'>:"X:$B ;$D
Hl'>ก$F">
- AI:8#3 > IM
- USFDA Preg Cat C

-

- 8# 9:8#3 > IV

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Hydrocortlsone
Sodium succinate
(Solu - Cortef)
100 mg ; powder 

/    

/ 
- Glucocorticoid, Mineralocorticoid
- Acute adrenal insufficiency : IM, IV ;
Infant & young children : 1 t 2 mg/ kg 8%>L ก
$@$:8# 25 t 150 mg/ day FJX>:8#3\ก 6 t 8 ;9.

กT> : 1 t 2 mg/ kg 8%>L ก$@$:8# 150 t 250
mg/ day FJX>:8#3\ก 6 t 8 ;9. 
: 100 mg IV bolus 8%>L ก$@$:8# 300 mg/
day FJX>:8#3\ก 8 ;9. 8&':8# IV continuous
infusion $ $ 48 ;9.
- Inflammation : IM, IV ;

ก : 1 t 5 mg/ kg/ day FJX>:8#3\ก 12 t 24 ;9. 
: 15 t 240 mg 3\ก 12 ;9.
- Shock: IM, IV ;

ก : 50 mg/ kg 8%>L ก$@$ 4 ;9. :8#E '4ก 1 A@>
F%D/ 8&' :8#8%>L ก$@$ 24 ;9. '4กA@>8$~_> 
: 500 mg t 2 g 3\ก 2 t 6 ;9.
IM, Direct IV, IV Infusion   

!

D5S/2, D5S, NSS, - Direct IV, IM : %D% E(#
D5W, D10W,
IE$@Y ก%_$, NSS 2 ml
RINGER
- IV Infusion : !L&'L >(#IE
" %D% E34_:;#G(# 100 ml
!f&_':8#G(#AI 9!)#9)#$ 1
mg/ ml 

- IM, Direct IV :
100 mg/ 30 I=$ 34
- IV infusion : J=8 E $ $
กIX 20 $ 34 

" #/ $
- !9&_'%D% EF%D!L&'L >F%#IA>?I 3 I$34_'\m8BN9=8#'>
ก  ! : Serum glucose, BP, Weight, electrolytes

- USFDA Preg CatC: D in first trimester

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/  

D5W, NSS
Heparin injection - Hl'>ก$F%Dก thromoembolic
disorders

ก :
- Intermittent IV !=_9?#$(#IE)$ ( 50 t 100
units/kg ?X'L ก$@$:8# 50 t 100 units 3\ก
4 ;9
- IV Infusion !=_9?#$(#IE)$ ( 50 units/ kg
?X'L ก$@$:8# 15 t 25 units/ kg/ hr 8 ก
LY !Hn$:8#!f=_9)$ (A@>%D 2 t 4 units/ kg/ hr
3\ก 6 t 8 ;9. ? 9LY !Hn$ 
:
- Intermittent IV !=_9?#$(#IE)$ ( 10,000
units ?X'L ก$@$:8# 50 t 70 units/ kg (5,000
t 10,000 units) 3\ก 4 t 6 ;9.
- IV Infusion !=_9?#$(#IE)$ ( 50 units/ kg
?X'L ก$@$:8# 15 t 25 units/ kg/ hr K(E:8#
FJJ continuous infusion !f=_9)$ (A@>%D
5 units/ kg/ hr 3\ก 4 ;9.

Direct IV, Intermittent IV, IV Infusion 

!
- Intermittent IV Injection ' L
G9X?#'>!L&'L >E 8&'!L&'L >
(#IE NSS 50 - 100 ml
- IV infusion : standard
diluents : D5W :$'? "XI$
25,000 unit/ 500 ml )'>
D5W 

IM 

- Direct IV : :;#A@>FกK(E:8#bX $" E
:8#" $@Y 34_!)# ก$G(# K(E:8# 5000 units
:;#!I% 1 $ 34 :$!(Mก:;#)$ ( 50 units/
kg :$!I% 9 กกIX 1 $ 34
- Intermittent IV Infusion : :8#E 34_G9XG(#
!L&'L >8&'!L&'L >:$ 50 t 100 ml NSS
bX $3 > infusion pump
- Continuous IV Infusion : :;# infusion
pump :$!I% 24 ;9. K(E3_IGHLD:8#
:$'? !MI 1000 units/ ;9. F?X)~@$กJ
)$ (E 34_?#'>ก 
- Subcutaneous : :;#กJก :8# heparin
FJJ fixed low-dose ()$ (E 5000 t
7500 unit 3\ก 12 ;9. ) G9XLY !Hn$?#'>
!L&'L >E 

" #/ $
- ก }4(E :8#}4(FJJ intrafat 8&' deep subcutaneous
AI}4(J=!Im abdominal fat layer 8X >L ก"D(&'9 กกIX 2
$=@I 8%>}4(:8#ก(J=!Im34_}4(!J ] 5 - 10 I=$ 34 8# 9$I(
J=!Im34_}4(F%D!H%4_E$34_}4(A@>?X'GH!f&_'Hl'>ก$ก !ก=(
hematoma
- " %D% E34_!L&'L >F%#I94AI 9A>?I 24 ;9.
- " %D% E34_E>G9XG(#!L&'L >8%>!HŽ(:;#94AI 9A>?I 30 I$
- 8# 9:8#E K(EI=‚4 IM !$&_'>L กLD3Y :8#DA E!A&'> HI(
J=!Im34_}4( (Hematoma)
- ' ก )'>ก G(#E !ก=$)$ (A&' B ID!%&'(''ก K(EE
?# $f=A&' Protamine sulfate 1 mg ?X' heparin 100 units
F%D8E\(ก :8#E heparin y# 94 Progressive immune
thrombocytopenia !ก=()~@$
ก  !: Platelet counts, aPTT, hemoglobin,
hematocrit, sign of bleeding, ?IL'\LL D8 occult
blood
- AI?ILAX aPTT กX'$ก :8# heparin F%D?IL?=(? 9
!9&_':8#E GHF%#I 6 - 8 ;9. 8&'8%>L ก94ก HJ)$ (E 6 8 ;9. K(E3_IGH aPTT 34_:8#b%ก ก AI'ENXD8IX > 1.5
t 2.5 !3X )'>AX Hก?= (AX aPTT )'>bN#HpIEกX'$:;#E )

- USFDA Preg CatC

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

Hyoscine t N Butylbromide (Kanin
injection) 20 mg/ ml
Imipenem +
Cilastatin (Tienam)
500 mg + 500 mg

- Antispasmodic Agent : 1 - 2 amp,
Max : 5 amp daily
SC, IM, slow IV
- Antibiotic, Anaerobic, Carbapenam
- )$ (ก :8#E 250 mg - 1000 mg 3\ก
6 - 8 ;9. )~@$กJAI 9\$F>)'>ก ?=(!;&@'

Sterile water for
Injection (SWFI)

Insulin, regular
(RI)
100 unit/ 10 ml

Intermittent IV, not for Direct infusion
- Antidiabetic agent
- Dose LDHJ? 9D(J$@Y ? %
:$!%&'(
IM, SC, Direct IV, Infusion 

!
Direct IV : !L&'L >(#IE
SWFI 35 ml

D5W, D10W, NSS, - b"9E 500 mg กJ
Ringer, NSS/2
" %D% E34_:;#G(#10 ml F%#I
!L&'L >?X''EX >$#'E 100 ml
- b"9E 1 g กJ" %D% E
250 ml (NSS)

0.45 % NaCI, NSS - Direct IV : G9X?#'>!L&'L >
}4(!)# 3 > 3 - way
- IV Infusion : !L&'L >:$
" %D% E34_:;#G(#:8#G(#
100 u/ 100 ml 

Direct IV :8#;# :$ 1 $ 34

- 500 mg :8#$ $ 20 - 30
$ 34
- 1 g :8#$ $กIX 40 t 60
$ 34 (AI 9!)#9)#$"N>"\(G9X
AI!ก=$ 5 mg/ ml)

50 EN$=?/ $ 34 

" #/ $
- DI>ก :;#:$bN#HpIEKA8I:LLD3Y :8#!ก=( Tachycardia
- y# !Hn$E !9M(FJJ release form 8# 9J(8&'!A4@EI
- USFDA Preg CatC
- 8 กbN#HpIE!ก=(A%&_$G"#' !L4E$AI%('? !MI:$ก :8#%> 
DI> anaphylaxis :$ก :8#E A@>Fก
- 8%>%D% EF%#I(#IE" %D% E34_:;#G(#A>?I 4 ;9.34_
'\m8BN9=8#'> F%D 24 ;9. 34_'\m8BN9= 4 '>a !€%!€4E"
(Eก!I#$:;# NSS 'ENX$ $)~@$ 10 ;9.
34_'\m8BN9=8#'> F%D 48 ;934_ 4 '>a !€%!€4E"
- USFDA Preg CatC
- " 9 y!กMJ34_'\m8BN9=8#'>G9X!ก=$ 37 '>a !€%!€4E" $ $ 1
!(&'$
- ก :8#3 > IV LD:;#G(#!}f D Regular insulin !3X $@$
- USFDA Preg CatC Eก!I#$ Lispro Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Ketamine
(ketalar)
50 mg/ ml, 10 ml
(500 mg/ 10 ml) 

/    

/    

!

- General anethetic, :;#;ก$Y ก "%J
:$ก bX ?()$ (!%Mก
)$ (E !=_9?#$"Y 8J;ก$Y ก "%J

ก :
- IM : 3 t 7 mg/ kg
- IV : ;XI>)$ (ก :;#E Hก?=A&' 0.5
t 2 mg/ kg "Y 8J!8$4_EI$Y ก "%J
!f&_'3Y 8?yก !%Mก$#'E:;#)$ ( 0.5 t
1 mg/ kg "Y 8J!8$4_EI$Y ก "%J
3_IGH:;#)$ ( 1 t 2 mg/ kg
maintained (#IE)$ ( 1/ 3 t 1/ 2 )'>
)$ (!=_9?#$ 
:
- IM : 3 t 8 mg/ kg
- IV : : ;XI>)$ (ก :;#E Hก?=A&' 1 t
4.5 mg/ kg "Y 8J!8$4_EI$Y ก "%J
3_IGH:;#)$ ( 1 t 2 mg/ kg
maintained (#IE)$ ( 1/ 3 t 1/ 2 )'>
)$ (!=_9?#$

D5W, NSS, SWFI

- Direct IV : !L&'L >:8#G(#
1 mg/ ml (1 amp :$
" %D% E 500 ml)
- IV Infusion : !L&'L >:$
" %D% E34_:;#G(# 500 8&'
250 ml (1 t 2 mg/ ml)

IM, IV, Continuous IV Infusion

(E }4( IV " 9 y!L&'L >
(#IE" %D% E F%DAI 9
!)#9)#$"\(3# EG9X!ก=$
2 mg/ ml) 

- IM, Direct IV : :8#;# ]
'EX >$#'E1 $ 34
- IV Infusion: '? :8#E
0.5 mg/ kg/ min
(G9XF$D$Y ก :8#E FJJ
Intermittent infusion) 

" #/ 7$
- !กMJE :8#f#$F"> 8# 9:;#8 กE !ก=(?ก?Dก'$
- G9X!)# ก$กJ Barbiturate 8&' Diazepam LD?ก?Dก'$ 
กUV: 8%>L กก :8#E single dose
Anesthesia: IM 12 - 25 $ 34 IV 5 - 10 $ 34
Analgesia: IM 15 - 30 $ 34
Amnesia: 'ENXD8IX > 1 - 2 ;9.
Recovery: IM 3 - 4 ;9. IV 1 - 2 ;9. 
7$ :
- Ketamine LD3Y H•=ก=E K(E?>กJ Barbiturates
!f D}D$@$G9XAI:8#E 3@>"'>K(E :;# Syringe XI9ก$
- !$&_'>L ก ketamine LD94b%3Y :8#!ก=(' !L4E$G(# (>$@$!f&_'
Hl'>ก$ก "Y %ก!)# H'(L~>AI:8#E FกXbN#HpIE!9&_'3#'>IX >
- ก :8#E )$ ("N>!ก=$GH8&'!MI!ก=$GHLD3Y :8#!ก=( respiratory
depression, apnea, hypertension
ก  !: Cardiovascular effects, heart rate, blood
pressure, respiratory rate, transcutaneous O2 saturation :$
bN#HpIEAI 9($K%8=?"N>8&'KA8I:LAI?=(? 9 ECG D8IX >
ก :8#E (#IE
- overdose : ก 8 E:LyNกก( ' L!f=_9AI 9($K%8=?F%D'?
ก !?#$)'>8I:L F?X:$J > E' L!ก=(?>)# 9
- กกE: !กMJก$F"> F%D34_'\m8BN9=G9X!ก=$ 8 - 15 OC
- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Lignocaine
injection
(Xylocard) 

/    

/    

!  

" #/7$

- :;#ก B ID ventricular arrhythmias L ก
myocardial infarction, cardiac
manipulation, digitalis intoxication !Hn$
drug of choice :$ก ก ventricular
ectopy, ventricular tachycardia,
ventricular fibrillation

ก :
- Endotracheal, intraosseous, IV : Loading
dose 1 mg/ kg " 9 y:8#€@Y G(#'4ก:$!I%
10 t 15 $ 34'4ก 2 A@> 8%>L ก:8# loading
dose F%#I!=_9:8# IV continuous :$'? !MI
20 t 50 mcg/ kg/ min bN#HpIE CHF ?#'>
%()$ (E %> 
:
- Antiarrythmias : Loading dose
1 t 1.5 mg/ kg K(E IV bolus 2 t 3 $ 34 :8#
€@Y G(#:$)$ ( 0.5 t 0.75 mg/ kg
:$ 5 t 10 $ 34 L$G(#)$ (I93@>89(!3X กJ
3 mg/ kg
Continuous infusion 1 t 4 mg/ min
- Ventricular fibrillation : !=_9(#IE)$ (
1.5 mg/ kg :8#€@Y G(#:$)$ ( 0.5 t 0.75 mg/
kg 3\ก 5 t 10 $ 34 ? 9(#IEก :8#FJJ
continuous infusion : 1 t 4 mg/ min

D5W, NSS,
Ringer's and
sodium
bicarbonate
solution

- Direct IV : y# 94AI 9!)#9)#$
20 mg/ ml G9X?#'>!L&'L >
- Continuous IV Infusion : :;# 1 g
)'>E !L&'L >(#IE" %D% E34_
!)# ก$G(# LY $I$ 1000 ml LDG(#
AI 9!)#9)#$ 1 mg/ ml AI 9
!)#9)#$G9XAI!ก=$ 8 mg/ ml
- "Y 8JE :$AI 9!)#9)#$ 40, 100
8&' 200 mg/ ml LD:;#"Y 8J
infusion €~_>?#'>!L&'L >กX'$:;#
!3X $@$ y# 8 กG9XG(#!L&'L >' L3Y
:8#!ก=( cardiac arrest, seizures
8&'!"4E;4I=?G(#

กX'$:8#E K(E IV Infusion :8#}4(
E direct IV กX'$ !f&_':8#G(#D(J
E :$!%&'(:$)$ (ก 'EX > 
I(!MI
- Direct IV :8#:;# Xylocard 100
(100 mg/ 5 ml) :$)$ (
1 mg/ $@Y 8$ก?I 1 kg }4(!)# !"#$
;# ] K(E:;#!I% 2 $ 34 F%DAI
!=_98E(E !)# !"#$B E:$ 10 $ 34
' L:8#E :$)$ (!(4EI$4@G(#3\ก
10 - 20 $ 34 F?XG9XAI!ก=$
300 mg Lignocaine :$ 
DED!I% 1 ;9.
- IV infusion :8#:;# Xylocard 500
(100 mg/ ml) F%D:;# infusion
pump 8&' microdrip '? ก 
8E(34_F$D$Y A&' 2 - 4 mg/ min
y# 8E(!)# !"#$!MI!ก=$GH' L3Y :8#
!"4E;4I=?G(#

- " %D% E8%>b"9F%#I?#'>:;#:8#89(B E:$ 12 ;9. 
7$ :
- ?IL"'J'? ก 8E()'>$@Y E 8 ก8E(!)# !"#$K%8=?
!MI!ก=$GH' L3Y :8#!"4E;4I=?G(#
- กm434_!ก=(' ก ;M'A 8I:L8&'?J%#9!8%I AI%()$ (
E %>
- )$ (:;#:$ก ก 34_:8#GI#$4@!Hn$!f4E>AY F$D$Y !3X $@$ 
D(JE :$ plasma F%D)$ (:;#AIHJ? 9AI 9!89 D"9
)'>F?X%DJ\AA% !$&_'>L ก ก ?'J"$'>?X'E 34_F?ก?X >ก$
- :8#:;#E )$ (?_Y "\(34_" 9 yAIJA\9B ID arrythmias G(#
( therapeutic level 1.5 t 5 mcg/ ml,
toxic level > 5 mcg/ ml)
ก  ! :
- D8IX >ก :8#E AI?=(? 9 ECG 'EX >?X'!$&_'>F%D
?=(? 9ก !ก=( prolonged PR interval 34_9 กกIX 0.2 I=$ 34
8&'94 QRS complex 9 กกIX 0.12 I=$ 34 8&'B IDก !%I
%>)'> ventricular arrythmias
- ?=(? 9ก !ก=(f=)'>E F%DD(J AST, ALT, BUN
Creatinine F%DD(J electrolytes
overdose : €~9 "J"$ coma ;ก ก 8 E:LyNกก( 94f=?X'
8I:L ; "_$ GI disturbance
- !กMJE :$'\m8BN9=34_ 25 OC 8&'?_Y กIX

Direct IV, IV Infusion

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Lidocain
1% , 50ml
2%, 50ml 

/    

/   

- Local anesthetic, Antiarrthymic agent
D5W, D5S/2,
- Antiarrthymic :
0.45% NaCI, NSS,
!(Mก : IV ; loading : 1 mg/ kg ? 9(#IE IV
RINGER
continuous infusion y# 8X >ก$9 กกIX 15 $ 34
' L:8# bolus !)M934_"'>:$)$ ( 0.5 t 1 mg/ kg
G(#
IV continuous infusion : 20 t 50 µg/ kg/ min
y# bN#HpIE shock !Hn$KA?J, cardiac arrest,
mild CHF :8#)$ ( 20 µg/ kg/ min
bN#:8<X : IV ; !=_9?#$(#IE)$ ( 1 t 1.5 mg/ kg
8%>L ก$@$ 5 t 10 $ 34 ' L€@Y (#IE 0.5 t 0.75
mg/ kg bolus K(E)$ (E I9G9X!ก=$ 200 t 300
mg :$D8IX > 1 ;9. 8&' 3 mg/ kg )'>)$ (
E I93@>89( 

! 

- IM, Direct IV : !)#9)#$1%,
2% G9X?#'>!L&'L >
- Intermittent IV : %D% EE
1 g :$" %D% E34_:;#G(#
'EX >$#'E 250 ml
- IV infusion : %D% EE
2 g :$ D5W 250 ml F%D:;#
infusion pump

- IM, Direct IV : 25 - 50
$ 34 y# :8#!MI!ก=$GHLD3Y :8#
;กG(#
- intermittent IV : 1 t 4 mg/
$ 34
- IV infusion : :;# microdrip
(60 drops/ ml) 8&' infusion
pump

IM, Direct IV, Intermittent IV
Lincomycin
(Lingo)
600 mg/ 2 ml

- Antibiotics ( Lincosamides group)

ก : IM ; 10 mg/ kg :8#3\ก 12 t 24 ;9.
IV ; 10 t 20 mg/ kg/ day FJX>:8#3\ก 8 t 12 ;9. 
: IM ; 600 mg :8#3\ก 12 t 24 ;9.
IV ; 600 t 1000 mg :8#3\ก 8 t 12 ;9.
)$ ("N>"\(G9X!ก=$ 8 g/ day

IM, IV Infusion

D5S, D10S, D5W, - !L&'L > : 1 amp :$
D10 W, RINGER " %D% E34_:;#G(#'EX >$#'E
250 ml (b"9F%#IAI 9
!)#9)#$G9X!ก=$ 1 g/ 100 ml
)'>" %D% E) 

" #/ $
- !9&_'!L&'L >F%#IA>?I 24 ;9.
- 8%>L ก!HŽ(:;#F%#I94AI 9A>?I 30 I$
- A$G)#34_G(# IV Infusion $ $] DI>ก !ก=(
thrombophlebitis

- USFDA Preg Cat B :As LA& cardiac drug
- IV infusion J=8 $ $กIX 1 - !L&'L >F%#IAI:;#B E:$ 24 ;9. 34_'\m8BN9=8#'>
;9.
- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Meropenem
1g 

/    

/   

- Antibiotic, Carbapenem
NSS, D5W, D10W,

กก : 20 mg/ kg/ dose :8#3\ก 12 ;9.
D5S , RINGER

ก > 3 
(< 50 kg) : 10 t 40 mg/ kg/
dose :8#3\ก 8 ;9.

ก456ก > 50 kg   : 500 mg - 2 g
3\ก 8 ;9. ? 9AI 9\$F>)'>KA

Direct IV,IV Infusion
Methylprednisolone - Corticosteroid system, Anti t inflammatory,
(Sodium succinate) Immunosuppressant
(Solu - Medrol)
- Shock : 30 mg/ kg :8#!I% $ $กIX 15 $ 34
1000 mg
- Immunosuppressant : 0.5 - 2 g
(1 gm/ 16 ml)
- Anti t inflammatory : IM ; 10 t 80 mg/ day
IV ; 10 t 40 mg F%D:8#€@Y (#IE IV 8&' IM
F%#IF?Xก ?'J"$'>
3\ก 1 - 2 I$
IM, Direct IV, IV Infusiion

NSS, D5S, D5W 

! 

- Direct IV : %D% E(#IE
- Direct IV : 3 - 5 $ 34
SWFI :8#AI 9!)#9)#$ 50 mg/ (H=9 m 5 - 20 ml)
ml (b>E 500 mg %D% E:$ - Infusion : 15 - 30 $ 34
10 ml, b>E 1000 mg
%D% E:$ 20 ml)
- IV Infusion : %D% E:$
" %D% E34_:;#G(# 50 - 200
ml
- IM Direct IV : %D% E(#IE
?I3Y %D% E34_:8#9 8&'
bacteriostatic water 2 ml
- IV Infusion : !L&'L >(#IE
" %D% E34_:)#G(# 50 ml

- IM Direct IV :
'EX >$#'E 1 $ 34
- Infusion:
125 - 500 mg: > 15 - 30$ 34
500 t 1,000 mg: > 30 $ 34
1000 - 1,500 mg: > 60 $ 34 

" #/ $
- %D% E:$ SWFI A>?I 2 ;9. 34_'\m8BN9=8#'> F%D 18 ;9.
!9&_':"X:$?N#!EM$
- " %D% E34_:;# Infusion !Hn$ D5W 94AI 9A>?I 1 ;9. 34_
'\m8BN9=8#'> F%D 8 ;9. !9&_':"X:$?N#!EM$
- y# %D% E:$ NSS LD94AI 9A>?I34_'\m8BN9=8#'> 4 ;9
F%D :$?N#!EM$ 24 ;9.

- USFDA Preg Cat B
- 8%>L ก%D% EF%#I!กMJ34_'\m8BN9=8#'>G(#$ $ 48 ;9.
- y# )$ (E < 250 ml LD:8#3 > IM, Direct IV F%D IM
LD:8#A@>%D 5 ml !f&_'%(ก DA E!A&'>!$&@'!E&_'

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

Metoclopramide
(Plasil)
10 mg/ 2 ml

- Antiemetic, Prokinetic agent

ก : Gastrointestinal hypomotility : IM,
IV ; 0.1 mg/ kg/ dose :8#G(#"N>"\( 4 A@>?X'
I$ )$ ("N>"\(G9X!ก=$ 0.5 mg/ kg/ day
Antiemetic : IV ; 1 t 2 mg/ kg/ dose :8#
30 $ 34กX'$G(#JE !A94JY J( F%D3\ก 2 t 4
;9. :8#G(#"N>"\( 5 A@>?X'I$ )$ ("N>"\(G9X
!ก=$ 5 - 10 mg/ kg/ day 
: Gastrointestinal hypomotility : IV
; 10 mg ' L:8#G(#$ $y~> 10 I$
Antiemetic : IV ; 1 t 2 mg/ kg/ dose :8#
30 $ 34กX'$G(#JE !A94JY J( :8#G(#"N>"\( 5
A@>?X'I$
IM, Direct IV, Intermittent IV
- Antibiotic, Antiamoebic, Anaerobic
- Anaerobic infection

ก : IV ; 30 mg/ kg/ day FJX>:8#3\ก 6 ;9. 
: IV 500 mg/ dose :8#3\ก 6 t 8 ;9.
)$ ("N>"\(G9X!ก=$ 4 g/ day
IV Infusion

D5W, D5S/2,
D5S, RINGER,
NSS

Metronidazole
500 mg/ 100ml
(0.5%, 100 ml )

Mitomycin - C
5 mg

- Antineoplastic agent, Antibiotic
- Single agent therapy : IV ; 20 mg/ m2
:8#3\ก 6 t 8 "H( 8C
- Combination therapy : IV ; 10 mg/ m2
:8#3\ก 6 t 8 "H( 8C
Direct IV 

!
- IM, Direct IV : G9X?#'>!L&'L >
- Intermittent IV :
)$ ( > 50 mg !L&'L >:$
" %D% E34_:;#G(#'EX >$#'E 50 ml 

- IM, Direct IV : 1 - 2 $ 34
!f&_'%(ก !ก=( restlessness
L กก }4(E !MI
- Intermittent IV : 'EX >$#'E
15 $ 34

NSS, D5W,
RINGER

- %D% E:$$@Y ก%_$, NSS 4.4 ml F%# Slow infusion F?X%D single
I!L&'L >?X':8#AI 9!)#9)#$G9X!ก=$ 8 dose 'EX >$#'E 1 ;9.
mg/ ml

NSS, D5W,
RINGER

- b>E 5 mg %D% EกJ$@Y ก%_$8&' - Direct IV :
" %D% E34_:;#G(# 10 ml (conc. 0.5
slow 15 - 10 $ 34
t 1 mg/ ml) :8#bX $ Y - tube 8&' 3 - Infusion :
t way stopcock
slow 15 - 30 $ —4
- IV solution กX'$F%D8%>:8#E 

" #/7$
- 8%>L ก!L&'L >F%#A>?I 24 ;9.
-:8#กX'$:8# chemotherapeutic agent '&_$A~_>)_IK9>

- USFDA Preg Cat B
- 8%>!L&'L >F%#IAI!กMJ:8#f#$F">
- 8 กF;X:$?N#!EM$?IE ' L?กb%~กG(#F?Xb%~ก$4@LD%D% EG(#!'>
!9&_''\X$)~@$F%DLD" 9 y:;#G(# (F$D$Y :8#!กMJ34_ 15 - 30 '>a
G9XAI!กMJ:$?N#!EM$) :;#B E:$ 24 ;9.
- !HŽ(F%#I:;#G(# 30 I$
- USFDA Preg Cat B (' L8# 9:;#:$G?9 aFก)
- " %D% E34_G(#A>?I 14 I$:$?N#!EM$ 7 I$34_'\m8BN9=8#'>
Hl'>ก$F"> (conc. 0.5 t 1 mg/ ml)
- 8 ก" %D% E34_G(#!L&'L >?X':$ NSS, Sodium lactate
(conc. 20 t 40 µg/ ml)
A>?IG(# 12 ;9. F%D 24 ;9. ? 9%Y (J34_'\m8BN9=8#'>
- USFDA Preg Cat X

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/    

! 

Magnesium
sulphate (Epsom
salt)
10% , 10 ml
50% , 2 ml

- :;#ก B ID hypomagnesemia, Hl'>ก$
ก ;ก:$ severe pereclampsia 8&'
eclampsia, Pediatric acute nephritis,
torsade de point, cardiac arrest
- Hypomagnesemia
Children :
IM, IV : 25 t 50 mg/ kg/ dose (0.2 t 04
mEq/ kg/ dose) 3\ก 4 - 6 ;9. 3 t 4 dose
)$ ("N>"\(G9X!ก=$ 2000 mg (16 mEq)
maintenance IV 30 t 60 mg/ kg/ day (0.25
t 0.5 mEq/ kg/ day)
Adult : IM, IV : 1 g 3\ก 6 ;9. :8# 4 dose y# 
\$F>' L:8# 8 t 12 g/ day
- ก Seizures :Children: IV : 20 t 100
mg/ kg/ dose 3\ก 4 - 6 ;9. กm434_\$F>
' L:8#G(#"N>y~> 200 mg/ kg/ dose
- ก Eclampsia F%D pre-eclampsia :
Adult : IM ; 1 - 4 g 3\ก 4 ;9., IV ; !=_9?#$:8#
4 g L ก$@$!H%4_E$!Hn$:8# IM 8&' IV Infusion
1 - 4 g/ hr )$ ("N>"\(G9X!ก=$ 30 t 40 g/ day
F%D'? !MI:$ก :8#G9X!ก=$ 1 t 2 g/ hr
- Life threatening arrhythmia : IV ; 1 t 2 g
(8 t 16 mEq) b"9(#IE D5W 100 ml :8#$ $
5 t 60 $ 34 ? 9(#IE IV infusion 0.5 t 1 g/
hr 8&':8# 3 t 20 mg/ min $ $ 5 t 48 ;9.
IV, IM, IV push, IV Infusion

NSS, D5W,
RINGER

- Direct IV : !)#9)#$ 10%
G9X?#'>!L&'L >
- Intermittent IV : ก$;ก
- !L&'L > 4 g :$" %D% E34_:;#G(#
250 ml
- !L&'L > 5 g :$" %D% E34_:;#G(#
1000 ml

- IM, IV push AI94ก !L&'L >E F%D
:;#E 34_94AI 9!)#9)#$G9X!ก=$ 20% (200
mg/ ml) '? !MI:$ก :8#E G9X!ก=$ 1.5
ml/ min 8&' 150 mg/ min
- Life - threatening arrhythmia:
IV push : 1 - 2 g (8 - 16 mEq)
!L&'L >:$ D5W 100 ml :8#E $ $
5 - 60 $ 34 F%D? 9(#IEก :8#FJJ
IV Infusion '? !MI"N>"\(:$ก 8E(E
0.5 -1 g/ hr
- IV Infusion : :;#!I% :$ก 8E(E
$ $กIX 2 - 4 ;9. (G9X!ก=$ 125 mg/
kg/ hr 8&' 1 mEq/ kg/ hr) '? !MI
"N>"\(:$ก 8E(E !)# 8%'(!%&'( 1 - 2
g/ hr
- กm4}\ก!}=$ (;ก) ' LLD:8# 4 g/ hr
** Maximum rate of infusion: 2 gm/
;9. Hl'>ก$ hypotension
** )$ (E "N>"\(G9XAI!ก=$ 30 - 40 g/
day '? ก :8#E infusion "N>"\(
G9X!ก=$ 1 - 2 g/ hr

( IV Infusion: !L&'L >E :8#94AI 9
!)#9)#$"N>"\( 100 mg/ ml) 

" #/ 7$
- 8# 9b"9I9กJ fat emulsion, calcium
gluceptate, clindamycin, tolbutamine,
hydrocortisone (same syringe), nafcillin,
polymixin B, procaine hydrochloride,
tetracyclines, thiopental
- monitor : BP, serum Mg (Hl'>ก$ overdose),
diarrhea, arrthymias, hypotension, CNS 
7$ :
- 8# 9:;#กJbN#HpIEKAG?34_94 Clcr < 25 ml/ min
- ก :8#E (#IE'? !MI"N>?#'>DI>ก !ก=(
Hypotension
ก  !: Arrhythmias, hypotension,
diarrhea, respiratory and CNS depression 
D8IX >ก :8#E FJJ Rapid IV, ?=(? 9D(J
serum magnesium !f&_'Hl'>ก$ overdose
กกE$กA : room temperature (!กMJ34_
'\m8BN9=8#'>'\m8BN9=G9X!ก=$ 40 OC)
- 8# 9F;X!EM$!$&_'>L กE LD?ก?Dก'$

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/    

!  

" #/ 7$

Midazolam
injection
1 mg/ ml

- :;#!Hn$E ">JD>JHD" 3!f&_'!?4E9bN#HpIEกX'$ก bX ?(8&'ก 
?ILI=$=L}E 
กก กW
:
- "Y 8Jก :"X!A&_'>;XIE8 E:L ; IV Infusion 0.15 - 1 mcg/ kg/ min 
กY
กก5
:
- "Y 8Jก :"X!A&_'>;XIE8 E:L ; IV Infusion : 0.15 - 0.5 mcg/ kg/
min 
ก > 2 

ก :
- กX'$ก bX ?( : IM ; 0.08 mg/ kg กX'$ก bX ?( 30 - 60 $ 34 , IV ;
0.035 mg/ kg/ dose :8#€@Y G(#F?X)$ (E I9G9X!ก=$ 0.1 - 0.2 mg/ kg
- "Y 8Jก :"X!A&_'>;XIE8 E:L : IV : loading dose 0.05 - 0.2 mg/
kg ? 9(#IE IV Infusion 1 - 2 mcg/ kg/ min HJL$G(#b%ก ''ก3‚=ƒ
34_?#'>ก  )$ (Hก?=34_:;#A&' 0.4 - 6 mcg/ kg/ min
- Conscious sedation: IV : 0.05 mg/ kg กX'$ก 3Y 8?yก  3 $ 34 

- กX'$ก bX ?( : IM ; 0.07 - 0.08 mg/ kg กX'$ก bX ?( 30 - 60
$ 34 (' E\ < 60 H| :;# 5 mg, > 60 H| :;# 2 t 3 mg), IV ; 0.02 t 0.04
mg/ kg y# LY !Hn$:8#€@Y G(#3\ก 5 $ 34
- Conscious sedation: IV )$ (!=_9?#$ 0.5 - 2 mg slow IV $ $'EX >
$#'E 2 $ 34 HJ)$ (E ? 9?#'>ก ' L:8#€@Y G(#3\ก 2-3 $ 34
)$ (E I9G9X!ก=$ 2.5 - 5 mg
- Anesthesia : IV ; Unpremedicate pt : 0.3 t 0.35 mg/ kg
Premedicate pt : 0.15 t 0.35 mg/ kg
Maintenance : 0.05 t 0.3 mg/ kg y# ?#'>ก  8&':8# continuous IV
infusion 0.25 t 1.5 µg/ kg/ min
IM, IV, IV Infusion

0.9% NSS,
D5W,

ก !?4E9$@Y E "Y 8J:8#3 >
8%'(!%&'( : " %D% E
Midazolam L ก)I(E " 9 y
!L&'L >G(#K(E:;#" %D% E :$
'? "XI$ Midazolam 15 mg
:$" %D% E"Y 8J:8#3 >
8%'(!%&'( 100 - 1000 ml
AI 9!)#9)#$"N>"\()'>
" %D% EG9X!ก=$ 0.5 mg/ ml

- Deep IM : }4(!)# ก%# 9!$&@'9(
:8<X
- Slow IV : K(E:8#E $ $กIX
2 - 5 $ 34
- Continuous IV Infusion

- " %D% E34_b"9 D5W F%D NSS F%#I
LD94AI 9A>?I 24 ;9. !9&_'!กMJGI#34_
'\m8BN9=8#'>
- " %D% E34_b"9 Ringer F%#ILD94AI 9
A>?I 4 ;9. !9&_'!กMJGI#34_'\m8BN9=8#'>
- G9XLY !Hn$?#'>Hl'>ก$F">
ก  !: Respiratory and
cardiovascular status, blood pressure
LD?=(? 9:$กm434_:8# IV 
Z  [ : Midazolam !Hn$
short - acting benzodiazepines €~_>
bN#HpIE"XI$:8<XLD?&_$B E:$ 2 ;9. F?X
:$J > E' L?&_$:$ 6 ;9.

5% dextrose,
RINGER

- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/ 

Morphine sulphate
10 mg/ ml, 1 ml

- Analgesic, Narcotic
- Acute pain (moderate - severe)

ก > 6  (456ก < 50 kg) :
IM ; 0.1 mg/ kg :8#€@Y 3\ก 3 t 4 ;9. y# LY !Hn$
IV ; 0.05 t 0.1 mg/ kg :8#€@Y 3\ก 3 t 4 ;9. y# LY !Hn$
IV infusion range : 10 t 30 µg/ kg/ hr
- ' ก HI(8%>bX ?( : 0.01 t 0.04 mg/ kg/ hr
- :;#">JD>JF%DJ!3 ' ก HI(D8IX >ก 3Y
8?yก  : IV : 0.05 t 0.1 mg/ kg 5 $ 34กX'$ก 3Y
8?yก 
- :;#">JD>JF%DJ!3 ' ก HI(D8IX >3Y 8?yก 

กJกก= 12  : IV : 3 t 4 mg €@Y G(#3\ก 5 $ 34y#
LY !Hn$
- Acute pain (moderate - severe) 
: IM, IV, SC : 2.5 - 5 mg/ dose 3\ก 3 - 4 ;9.
AX'E] !f=_9)$ ()~@$34%D 1 t 4 L$G(#ก ?'J"$'>34_
?#'>ก 
IV, SC, Continuous infusion : 0.8 t 10 mg/ hr )$ (
E Hก?=G9XAI!ก=$ 80 mg/ hr
Epidural : !=_9?#$(#IE 1 t 6 mg :8# infusion ?X'(#IE
'? !MI 0.1 t 1 mg/ hr )$ (E "N>"\(G9X!ก=$ 10 mg :$
24 ;9.

IM, IV, SC, Continuous infusion  

Ringer, D5W,
D10W, NSS,
Dextran, DRinger, D-S,
0.45 % NaCI 

!  

" #/ $

- IV push: !L&'L >E (#IE
Sterile water for Injection
8&' D5W 'EX >$#'E 5 ml
AI 9!)#9)#$34_:;#
0.5 t 5 mg/ ml
- IV Infusion: !L&'L >E (#IE
D5W :8#94AI 9!)#9)#$
0.1 t 1 mg/ ml
8%>L ก!L&'L >F%#IAI:;#
3$34 ก!! 
\8 ! 

- }4(!)# ก%# 9 (IM) F%D}4(
!)# :?#b=I8$> (SC) $ $ 3 t
5 $ 34
- }4(!)# !E&_'8\#9"9'>F%DG)
"$8%>;@$$'ก (Epidural)
:;# ;$=(G9X94 preservative
- }4(!)# G)"$8%>
(Intrathecal)
:;#;$=(34_G9X94 Preservative
- IV Infusion :8#:$'? !MI
1 t 10 mg/ hr K(E:;#
Infusion pump
- IV push K(E$Y GH!L&'L >
:$ Sterile water for
Injection 4 - 5 ml }4('EX >
;# ] $ $ 4 - 5 $ 34

- 8 กE "% E?ILD!ก=("4!8%&'>8&'$@Y ? %F%D
8# 9:;#!9&_'94ก ?ก?Dก'$!ก=()~@$8&'94"4!8%&'>!)#9)~@$
- !กMJ:8#f#$F">
- 8%>!L&'L >F%#IAI:;#3$34
- ก :8#'EX >I(!MI' L3Y :8#ก(ก 8 E:L, AI 9($
K%8=??_Y G(# F%DA$G)#' LLDy~>? EG(#
- Monitor : pain relief, respiratory and mental
status, BP 
ก overdose : ก(ก 8 E:L 9X $? )E E AI 9
($K%8=??_Y 8I:L!?#$;# 8E\(8 E:L pulmonary
edema 

กกUV:
IM; peak 30 - 60 $ 34 
DED!I% 4 - 5 ;9.
IV ; peak 20 $ 34 DED!I%
4 - 5 ;9. 

! M :
E 94 2 NHFJJ A&'
1. 94 Preservative : ! 
E K(Eก 
- }4(!)# !E&_'8\#9"9'>F%DG)"$8%>;@$$'ก (Epidural)
- }4(!)# G)"$8%> (Intrathecal)
2. G994 Preservative (preservative-free solution)
" 9 y:8#G(#K(Eก 
- }4(!)# !E&_'8\#9"9'>F%DG)"$8%>;@$$'ก (Epidural)
- }4(!)# G)"$8%> (Intrathecal)

- USFDA Preg Cat C : D (y# :;#!Hn$DED!I% $ $
8&':;#:$)$ (34_"N>)

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/ 

Nitroglycerin, NTG - :;#:$B ID Congestive heart failure
(Glyecryl trinitrate) 34!_ ก=(XI9กJ myocardial infarction,
50 mg/ 10 ml
pulmonary hypertension,
hypertensive emergencies

ก : Continuos infusion ; )$ (E
!=_9?#$ 0.25 t 0.5 µg/ kg/ min !f=_9
)$ (A@>%D 1 µg/ kg/ min 3\ก 20 F%D
60 $ 34 ? 9?#'>ก 
)$ (Hก?=!3X กJ 1 t 3 µg/ kg/ min
)$ (E "N>"\(A&' 5 µg/ kg/ min 
:
)$ (E !=_9?#$ 5 µg/ min !f=_9)$ (A@>
%D 5 µg/ min 3\ก 3 t 5 $ 34 L$G(#
)$ ( 20 µg/ min y# bN#HpIEE>G9X
?'J"$'> :8#!f=_9)$ (A@>%D 10 µg/
min 3\ก 3 t 5 $ 34 K(E)$ (E "N>"\(
G9X!ก=$ 200 mcg/ min

Continuous IV Infusion   

!

NSS, D5W

- IV Infusion %D% E?IE 50 mg :$
" %D% E34_!89 D"9A&' NSS, D5W 250
8&' 500 ml 8&' %D% E?IE 100 mg :$
" %D% E 250 ml !f&_':8#G(#" D% E
AI 9!)#9)#$D8IX > 50 t 200 µg/ ml
- AI 9!)#9)#$"N>"\(G9X!ก=$ 400 µg/ ml  

" #/7$
- 8%>!L&'L >:$ glass container F%#IA>?I 48 ;9.
34_'\m8BN9=8#'> F%D 7 I$ !9&_'!กMJ:$?N#!EM$ 
7$ :
- Nitroglycerin !)# ก$G9XG(#กJy\>f% "?=ก;$=($=_9 PVC !$&_'>L ก
PVC LD(N(€~9?IE GI# L~>AI!?4E9E :$)I(Fก#I F%D:;# infusion
pack 34_3Y 9 L ก polyethylene (Non-PVC plastic)
- :8#:;#E 'EX >D9(DI>:$bN#HpIE severe hepatic 8&' renal
disease
- ' L!ก=(' ก HI(a4DF%DA%&_$G"#D8IX >:8#E
- ' L3Y :8#AI 9($%(?_Y %>'EX >9 ก 8I:L!?#$!MIb=(Hก?= !8>&_'
G8%9 ก กD"JกD"X E ก%# 9!$&@'กD?\ก '~('(:$;X'>'ก HI(
B E:$;X'>3#'> ' LfJก !ก=( paradoxical 8I:L!?#$;# b=(Hก?=
- ก :8#E AI:;# infusion pump
overdose : AI 9($K%8=??_Y 8$# F(> 89("?= HI(8I 8I:L!?#$
!MI methemoglobin AI 9($:$"9'>!f=_9)~@$ "J"$ !I4E$a4D
:L"_$ A%&_$G"# ' !L4E$ 8'J heartblock 8I:L!?#$;# %> coma ;ก
!"4E;4I=?
- Tolerance ' L!ก=()~@$ y# :8#9 กกIX 12 t 24 ;9.
- AIJL\:$B ;$DFก#ILDyNก(N(€JL ก plastic PVC
ก  ! : Blood pressure, heart rate
- !กMJE 34_'\m8BN9=G9X!ก=$ 25 OC !กMJ:8#f#$F">

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Nadroparin cal.
(Fraxiparin)
3800 iu/ 0.4 ml 

/    

/ 
- Anticoagulant
- Dose variable   

! 

-

-

-

NSS, D5W

- Direct IV : G9X?#'>!L&'L >:$ 
E opioid overdose 8&'
!L&'L >(#IE$@Y ก%_$, NSS 10 ml
:$ EDJJ8 E:LyNกก(
opioid
- IV Infusion : !L&'L >(#IE
" %D% E34_:;#G(#:8#G(#AI 9
!)#9)#$ 4 µg/ ml (1 amp/ 100
ml solution)
G9X?#'>!L&'L >' L:8#bX $
Y - tube 8&' 3 - way
stopcock

- IV push : :8#$ $กIX 30 I=$ 34
- IV : Loading 0.4 mg ? 9(#IE
infusion 0.4 mg/ hr (bN#:8<X) 8&'
0.024 t 0.16 mg/ kg/ hr (!(Mก)
- IV infusion : 3.7 µg/ kg/ hr

SC
Naloxone
0.4 mg/ ml, 1 ml

Neostigmine
(Prostigmine)
2.5 mg/ ml, 1 ml

- Antidote morphine Opiate intoxication
-
ก < 5   456ก < 20 kg :
IV ; 0.1 mg/ kg :8#€@Y 3\ก 2 t 3 $ 34 y# LY !Hn$
8&':8#3\ก 20 t 60 $ 34
-
ก > 5   456ก > 20 kg :
IV ; 0.2 mg/ kg :8#€@Y 3\ก 2 t 3 $ 34 y# LY !Hn$
-  : IV ; 0.4 t 2 mg :8#€@Y 3\ก 2 t 3 $ 34
y# LY !Hn$ K(E)$ (E "N>"\(G9X!ก=$ 10 mg
Sc, IM, Direct IV, IV Infusion
- Acetylcholinesterase inhibitor
- Myasthenia gravis diagnosis : IM ;

ก : 0.04 mg/ kg single dose 
: 0.02 mg/ kg single dose
- Myasthenia gravis treatment : IM, IV, SC ;

ก : 0.01 t 0.04 mg/ kg :8#3\ก 2 t 4 ;9. 
: 0.5 t 2.5 mg/ kg :8#3\ก 1 t 3 ;9.
K(E)$ ("N>"\(G9X!ก=$ 10 g/ 24 hr

IM, Direct IV

-

0.5 mg/ $ 34 

" #/7$
- }4(J=!Im8$# 3#'>K(EF3>!)M9%>?>GH34_;@$
subcutaneous A%# Eก }4( Insulin
- 8# 9F;X!EM$
- USFDA Preg Cat B
- ก :8#!)# IV LD!Hn$ route 34_$=E99 ก34_"\(
- 8%>L ก%D% EF%#I" %D% E94AI 9A>?I 24 ;9.

- USFDA Preg Cat C
- 8 ก:8# IV LY !Hn$?#'>'ENXB E:?#ก (NF%)'>Ff3EC
- !กMJE G(# 24 ;9.
- AI8E\(:;#E ก%\X9 anti t cholinesterase กX'$:8#E 'EX >
$#'E 8 ;9.
ก  ! : pulse, respiratory rate F%D blood pressure

- USFDA Preg Cat C ; D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Nitroprusside
Sodium
50 mg/ ml

Oxytocin
(Syntocinon)
10 u/ ml 

/    

/   

- Antihypertensive, Vasodilator
- Pulmonary hypertension

ก : IV infusion; !=_9(#IE 1 µg/ kg/ min
!f=_9G(#A@>%D 1 µg/ kg/ min 3\ก 20 t 60
$ 34 ? 9AI 9LY !Hn$
)$ (E Hก?= : 3 µg/ kg/ min
)$ (E "N>"\( : 5 µg/ kg/ min 
: IV infusion ; !=_9(#IE 0.3 t 0.5
µg/ kg/ min !f=_9G(#A@>%D 0.5 µg/ kg/
min
)$ (E Hก?= : 3 µg/ kg/ min
)$ (E "N>"\( : 10 µg/ kg/ min
IV Infusion
- Oxytocic agent
- Induction of labor 
: IV infusion ; 0.5 t 1 milliunits/
min !f=_9)$ (A@>%D 1 t 2 milliunits/ min
L$กD3_>G(#ก ?'J"$'>34_?#'>ก  ก 
:8#:$)$ ( 6 milliunits/ min LD3Y :8#G(#
ก ?'J"$'>:ก%#!A4E>‚9; ?=
- Postpartum bleeding :
IM ; )$ (E I9 10 units :8#8%>A%'(
IV ; 10 t 40 units b"9กJ" $@Y 1000
ml :8#:$'? 34_" 9 yAIJA\9uterine
atony G(#
IV Infusion

D5W

D5W, D10W,
0.45 NaCI,
Dextrose, NSS 

! 

- %D% EE 50 mg :$$@Y ก%_$ 2 - 3 - !9&_':8#E !Hn$DED!I% $ $G9X
ml F%#I!L&'L >?X':$ D5W H=9 m AI:8#!MIกIX 2 µg/ kg/ min
250 - 1000 ml
!f DLD3Y :8#!ก=(ก "D"9)'>
cyanide 9 ก!ก=$L$X >ก E3$
G9XG(#
- $@Y E 34_%D% E:89XLD94_"4
$@Y ? %'X'$8 ก!H%4_E$"4 F"(>IX
E "% E?I

- !L&'L >E 1 ml (10 unit) %>:$
- AI:;# infusion pump
" %D% E34_:;#G(# 1000 ml :8#94
oxytocin 10 milliunits/ ml FกIX>:8#
!)# ก$ 

" #/7$
- 8%>L ก%D% EF%D!L&'L >F%#IAI!กMJ:8#f#$F">F%D:;#
B E:$ 24 ;9.

- USFDA Preg Cat C
- !กMJ34_'\m8BN9= 2 - 8 OC 8# 9F;XF)M>'ENXG(# 30 I$
ก  ! : BP ' L!ก=( hypotension, cardiac
arrththemia uterine rupture, fluid intake F%D output, fetal

- USFDA Preg Cat X

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

Omeprazole
(Losec, Miracid)
40 mg

- Proton pump inhibitor
- )$ (ก :8#E 40 mg I$%DA@>
!f&_'AIJA\9 pH
- y# severe !=_9 80 mg bolus
8%>L ก$@$ 40 mg 3\ก 8 - 12 ;9
L$AJ 72 ;9. L~>:8#E }4( 8&'E :$ 
NHFJJJHD3 $)$ ( 40 mg I$%DA@>
IV
- Analgesic
- )$ (ก :8#E 300 mg 3\ก 6 ;9.
IM
- Antibiotics, Penicillins
bN#:8<X : IM ;
- Group A streptococcal upper
respiratory infection : 1.2 mu single
dose
- Rheumatic fever prophylaxis : 1.2 mu
:8#3\ก 3 t 4 "H( 8C 8&'FJX>:8#!(&'$%D 2
A@> A@>%D 0.6 mu
- Early syphilis : 2.4 mu single dose )# >
%D!)M9
- Syphilis 34_!Hn$9 $ $กIX 1 H| : 2.4 mu
}4()# >%D 1 !)M9 ?=(?X'ก$$ $ 3 "H( 8C
Note: G9XG(#DJ\:8#:;#:$ Neurosyphilis F?X
' L:8# "H( 8C%DA@>?=(?X'ก$ 3 "H( 8C
IM

-

Paracetamol
300 mg/ 2 ml
Penicllin G
Benzathine
1,200,000 mu 

! 

- %D% E(#IE?I3Y %D% E34_:8#9 

" #/7$
- 8%>L ก%D% EF%#I!กMJG(#$ $ 4 ;9.
- :8#;# ] !f D' LLD!ก=( Plebitis G(#

40 mg :$ 3 $ 34 8 ก:8#:$'?
34_!MI!ก=$GH' LHI(8&'!ก=(8%'(
!%&'('ก!"JG(#

-

-

-

- %D% Eb>E 1.2 mu :$$@Y ก%_$
3.6 ml

-

- USFDA Preg Cat C
- y 9HDI?=ก Ff#E )'>bN#HpIEกX'$}4(

-

- USFDA Preg Cat B
- 8%>%D% EF%#IAI:;#B E:$ 24 ;9.

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/ 

Penicillin G
- Antibiotics, Penicillins
sodium
- ?=(!;&@'3_IGH : IM, IV ; Infant :  

(Benzyl Penicillin 
M (day) Z
(unit/ kg/
8[ $ก (g)
,PenicillinG,PGS)
day)
100,000
1,000,000 U F%D > 7 > 2000
>
7
<
2000
75,000
5,000,000 U
<7
<7

> 2000
< 2000

50,000
50,000  

NSS, D5W 

  

(hr)
6
8
8
12

Infant 
ก : 100,000 t 250,000
unit/ kg/ day FJX>:8#3\ก 4 ;9. y# ?=(!;&@' 
\$F> :8#G(#y~> 400,000 unit/ kg/ day
FJX>:8#3\ก 4 ;9. K(E)$ ("N>"\(G9X!ก=$ 24
mu/ day 
: 2 t 24 mu/ day FJX>:8#3\ก 4 ;9.
)~@$กJก ?'J"$'>?X'E F%DAI 9 
\$F>)'>ก ?=(!;&@'
- Congenital syphilis
Newborn : 50,000 u/ kg/ day FJX>:8#3\ก
8 t 12 ;9. $ $ 10 t 14 I$
Infant : 50,000 u/ kg/ day :8#3\ก 4 t 6
;9. $ $ 10 t 14 I$
- Gonococcal infection : 100,000 u/ kg/
day FJX>:8#!3X ก$ 2 A@> (y# !(Mก' E\$#'E
กIX 1 "H( 8C FJX>:8#A@>%D!3X ] ก$ 4
A@>?X'I$)
IM, IV Infusion 

!
- IM : !)#9)#$G9X!ก=$
100,000 u/ ml %D% E 1 mu
F%D 5 mu :$$@Y ก%_$8&'
" %D% E34_:;#G(# 50 ml
- Infusion : !L&'L >E :$
" %D% E34_:;#G(#
1,000 ml - 2,000 ml 

- Intermittent IV: 1 t 2 ;9. ก :8#
'EX >I(!MI8&'9 ก!ก=$GH' L3Y :8#
!ก=(AI 9G9X"9(\%)'> electrolyte
8&';กG(#
- IV Infusion : ?%'( 24 ;9. 

" #/7$
- 8%>%D% EF%#IAI:;#B E:$ 7 I$34_'\m8BN9=?N#!EM$
- 8%>!L&'L >F%#IAI:)#B E:$ 24 ;9. 34_'\m8BN9=8#'>
- !H%4_E$34_}4(3\ก 48 ;9. !f&_'Hl'>ก$ phlebitis

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Phenobarbital
(Gardenal)
200 mg/ ml 

/    

/   

- Anticonvulsant
Loading dose IV :
Infant & children : 10 t 20 mg/ kg, single
dose 8&'FJX>:8# :$bN#HpIEJ > E' L:8#:$
)$ ( 5 mg/ kg/ dose 3\ก 15 t 30 $ 34 L$
AIJA\9' ก ;กG(# K(E)$ (I9G9X!ก=$ 40
mg/ kg
Adult : 300 t 800 mg 8%>L ก$@$:8# 120 t
240 mg/ dose 3\ก 20 $ 34 L$AIJA\9' ก 
G(# K(E)$ (E I9G9X!ก=$ 2000 mg
Maintenance IV :
Infant : 5 t 8 mg/ kg FJX>:8# 1 t 2 A@>?X'I$
Children 1  5  : 6 t 8 mg/ kg/ day FJX>
:8#I$%D 1 t 2 A@>
Children 5  12  : 4 t 6 mg/ kg/ day FJX>
:8#I$%D 1 t 2 A@>
Children >12  & Adult : 1 t 3 mg/ kg/
day FJX>:8#I$%D 2 t 3 A@> 8&' 50 t 100
mg :8# 2 t 3 A@>?X'I$

D5W, D10W
,0.45 %NaCI,
NSS

SC, IM, Direct IV 

!
- Direct IV : %D% E(#IE
$@Y ก%_$'EX >$#'E 3 ml 

- G9XAI:8#E !MIกIX 50 mg/ min
- ก :8#'EX >I(!MI' Lก(DJJ
3 >!(=$8 E:LG(# AI8%4ก!%4_E>ก 
}4(!)# 8%'(!%&'(F(> 

" #/7$
- " %D% E34_94?Dก'$G9XAI:;#
- 8%>L ก!HŽ(:;#!ก=$ 30 $ 34 :8#3=@>GH
ก  ! : phenobarb serum concentration, mental
status, CBC, LFTs, seizure activity

- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Phenytoin
(Dilantin)
250 mg/ 5ml 

/    

/   

- Anticonvulsant
- )$ (ก :8#E
Loading dose IV :
Infant & children : 15 t 20 mg/ kg single
dose 8&'FJX>:8#
Adult : 10 t 15 mg/ kg
Maintenance dose :
Infant & children : 5 mg/ kg/ day FJX>:8# 2
A@> F%#I? 9(#IE
)$ (E Hก?= :
6 !(&'$ t 3 H| : 8 t 10 mg/ kg/ day
4 H| t 6 H| : 7.5 t 9 mg/ kg/ day
7 H| t 9 H| : 7 t 8 mg/ kg/ day
10 H| t 16 H| : 6 t 7 mg/ kg/ day
Adult : 300 mg/ day 8&':8# 5 t 6 mg/ day
FJX>:8#I$%D 3 A@> y# !Hn$ extended
release :8#I$%D 1 t 2 A@>

NSS

Direct IV, Intermittent IV 

!
- Direct IV : G9X?#'>!L&'L >
- Infusion : !L&'L >:$ NSS
G9X!ก=$ 50 ml LD(434_"\(8&'
!L&'L >K(E total volume
G9X!ก=$ 100 ml 

D5W  

" #/7$

- Direct IV : G9X!ก=$ 50 mg/ $ 34
y# :8#!MI!ก=$GHLD3Y :8#!ก=(
Severe hypotension
- Intermittent IV : 4 ;9. :$'? 34_G9X
!ก=$ 50 mg/ min AI:8# NSS flush
:$!)M934_:8#!f&_'Hl'>ก$ก DA E!A&'>
!"#$!%&'(
- y# :8#:$'? !MI9 กกIX 20 mg
/min LD!f=_9K'ก "!"4_E>?X'ก Ff#

- !9&_'!L&'L >F%#IAI:;#3$34G9XAIF;X?N#!EM$ !f DLD3Y :8#E
?ก?Dก'$G(#
- 8%>L กb"9F%#I94AI 9A>?I 4 ;9.
- :8# Intermittent IV กm4 )$ (ก :;#E > 1 g
- y# $@Y E 94"4!8%&'>'X'$, :"" 9 y:;#G(#
- 8%4ก!%4_E>ก }4( IM !f DLDHI(9 ก
ก  ! : BP, EKG Vitalsign (IV used), plasma
phynytoin level, CBC, LFT

- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Potassium
chioride
Injection 

/    

/ 
- Electrolyte supplement
40 mEq/ m2/ day
- ก B ID hypokalemia

- Normal daily requirement : IV ;
Pre  mature infant : 2 t 6 mEq/ kg/ 24 hr
Term infant 0  24 hr : 0 t 2 mEq/ kg/ 24 hr
Term infant 0  24 hr : 0 t 2 mEq/ kg/ 24 hr
Infant > 24 hr : 1 t 2 mEq/ kg/ 24 hr
Children : 2 t 3 mEq/ kg/ 24 hr
Adult : 40 t 80 mEq/ kg/ 24 hr
- Treatment of hypokalemia
Children : IV ; 1 t 2 mEq/ kg :8#$ $กIX 1 t 2 hr
IV infusion ; )$ (G9X!ก=$ 1 mEq/ kg/ hr 8&' 40
mEq/ hr y# :8#!ก=$กIX 0.5 mEq/ kg/ hr bN#HpIEAI
G(#Jก ?=(? 9 EKG ?%'(!I%
)$ ("N>"\(G9X!ก=$ 3 mEq/ kg/ day 8&' 40 mEq/
m2/ day
Adult : IV intermittent infusion : 5 t 10 mEq/ hr
)$ ("N>"\(G9X!ก=$ 400 mEq/ day
intermittent IV, IV infusion  

D5S, D5S/2,
D5W, D10W,
RINGER 

!  

" #/7$

- กX'$:8#E LY !Hn$?#'>
!L&'L > K(EAI 9!)M9
)#$G9XAI9 กกIX 40
mEq/ L !I#$:$B ID
}\ก!}=$' L:;#AI 9
!)#9)#$"N>"\(!3X กJ 80
mEq/ L " %D% E34_
!L&'L >F%#IAI:;#
B E:$ 24 ;9.
(!L&'L >:$" %D% E
34_:;#G(# 100 - 1,000
ml)

- IV Intermittent infusion :$!(Mก :
'? ก :8#E G9X!ก=$ 1 mEq/ kg/ hr
8&' 40 mEq/ hr y# '? !MI9 กกIX
0.5 mEq/ kg/ hr Ff3ECAI(NF%A$G)#
'EX >:ก%#;=( F%D?=(? 9AX EKG 'EX >
?X'!$&_'>
- IV Intermittent infusion :$bN#:8<X :
'? ก :8#E G9X!ก=$ 5 - 10 mEq/ hr
y# '? !MI9 กกIX 5 mEq/ hr AI94
ก ?=(? 9DJJ8I:L'EX >?X'!$&_'>
F%DG9XAI!ก=$ 40 mEq/ hr )$ (E
"N>"\( 400 mEq/ day

- !9&_'!L&'L >F%#IA>?I 24 ;9. .
- KCl 80 mEq/ L :$ D5W 34_94 silica + aluminium LD
?ก?Dก'$ 
7$ :
- G9XAI:8#E 34_G9XG(#!L&'L >
- Potassium chloride inj AI:8#:$bN#HpIE34_94 urine flow
!f4E>f'!3X $@$
- :$bN#HpIE34_94B ID) ($@Y AI:8#" %D% E34_G9X94KHF?
"!€4E9LY $I$ 1 %=?กX'$:8#KHF?"!€4E9
- ก b"9KHF?"!€4E9A%'G(C %>:$y\>" %D% E34_F)I$
GI#' L3Y :8#!ก=(B ID hyperkalemia G(#!$&_'>L กก b"9
" %D% EB E:$y\>G9X(4f'(>$@$!9&_'b"9 KCL %>:$y\>
" %D% EAIFกIX>y\>GH9 !f&_'Hl'>ก$ก !ก=(AI 9G9X
"9_Y !"9')'>" %D% EE
- G9XAI:8# KCL 8%>ก bX ?(L$กD3_>bN#HpIE" 9 y
H˜"" ID''กG(#
ก  !: Serum potassium, glucose, chloride, pH,
urine output, cardiac monitor (if intermittent infusion or
potassium infusion rate > 0.25 mEq/ kg/ hr)
overdose : ก%# 9!$&@''X'$F>, paralysis, EKG b=(Hก?= (T
wave "N> P wave  J prolonged QRS complex),
ventricular arrythmias
กกE$กA : '\m8BN9=D8IX > 15 t 30 ° C
- USFDA Preg Cat A

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Propofol
injection
10 mg/ ml 

/    

/    

!

- :;#;ก$Y F%Dก B ID"%J

กJกก= 3  :
- ;ก$Y ก "%J : 2.5 t 3.5 mg/ kg :8#:$!I%
20 t 30 I=$ 34
- ก "B IDก "%J : IV Infusion
125 t 300 µg/ kg/ min (7.5 t 18 mg/ kg/ hr) 8%>L ก
$@$ 30 $ 34L~>%()$ (E %> 
:
- ;ก$Y ก "%J 
<=ก= 55  : :8#)$ (E !3X กJ
2 t 2.5 mg/ kg K(E3_IGH:8#)$ ( 40 mg Bolus 3\ก 10
I=$ 34 L$G(#ก ?'J"$'>34_?#'>ก F%D)~@$กJก 
!H%4_E$FH%>)'> vital sign 8%>L ก$@$L~>:8#E ?X':$
)$ ( 150 t 200 µg/ kg/ min $ $ 10 t 15 $ 34 %(
)$ (E %> 30 t 50 % :$;XI> 30 $ 34Fก)'>ก 
maintenance K(E)$ (Hก?=A&' 100 t 200 µg/ kg/ min
(6 t 12 mg/ kg/ hr) 
O D  JHL= hypovolumic : 1 t 1.5 mg/
kg 8%>L ก$@$L~>:8#E ?X':$)$ ( 0.05 t 0.1 mg/ kg/
min (3 t 6 mg/ kg/ hr)

D5W

G9XLY !Hn$?#'>!L&'L > F?Xy#
?#'>ก !L&'L > :8#!L&'L >:$
D5W :8#G(#AI 9!)#9)#$ 2 mg/ ml
(E 1 ml )'>b"9กJ" %D% E
4 ml)

IV Infusion  

" #/7$
- 8%>!L&'L >F%#IAI:;#3$34 b"9F%#I" %D% ELD94AI 9A>?I34_
'\m8BN9=8#'> 8 ;9. 
7$ :
- AX 3 >!B";L%$a "?CG9X!H%4_E$FH%>:$bN#HpIEKA?JF%DG?
- ก :8#E :$'? 34_!MI!ก=$GHLD94b%?X'DJJ8I:LF%D8 E:L
K(E!}f D:$bN#"N>' E\
- E ' L3Y :8#H˜"" ID!H%4_E$!Hn$"4!)4EI
- 8# 9:;#FbX$ก'>!%MกกIX 5 G9A'$
- ก  !: ก !ก=(B IDAI 9($K%8=??_Y F%D8I:L!?#$;# %>
B IDก 8E\(8 E:L' L!ก=(D8IX >ก ;ก$Y ก "%JF%D' L
!ก=($ $y~> 1 $ 34 AI;XIE8 E:L
- กกE: Hl'>ก$F"> '\m8BN9=D8IX > 2 t 22 °C ก@!
กZก $8  ! 

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Pethidine inj
50 mg/ ml
(Mepiridine) 

/    

/   

SWFI, D5W, NSS,
- Analgesic, Narcotic
Dextrose - saline

ก : IM, IV, SC: 1 t 1.5 mg/ kg
/dose 3\ก 3 t 4 ;9. K(E)$ ("N>"\(
G9X!ก=$ 100 mg/ dose 
: IM, SC: 50 t 150 mg/ dose
3\ก 2 t 4 ;9. ? 9AI 9LY !Hn$
(bN#HpIEA%'(:;#)$ ( 50 t 100 mg/
dose)
Slow IV ; !=_934_ 5 t 10 mg 3\ก 5 $ 34
? 9AI 9LY !Hn$ 
O D : IM ; 25 mg 3\ก 4 ;9. 

!  

" #/7$

- IM, SC : G9X?#'>!L&'L >
- IV push : !L&'L >(#IE
Sterile water for Injection,
NSS, D5W, dextrose-saline
combination LY $I$'EX >
$#'E 5 ml :8#!)#9)#$10 mg/
ml
- IV Infusion : !L&'L >:$
D5W :8#G(#AI 9!)#9)#$
0.1 t 1 mg/ ml ($=E91 mg/
ml)

- IM : :$กm4:;#กX'$bX ?(
:8#}4(E กX'$ก :8#E "%J
30 - 90 $ 34
- SC : :$กm4:;#กX'$bX ?(
:8#}4(E กX'$ก :8#E "%J
30 - 90 $ 34
- IV Infusion : K(Eก !L&'
L >E :8# 94AI 9!)M9)#$ 1
mg/ ml :$bN#:8<X:8#'? !MI
15 t 35 mg/ hr :$!(Mก!9&_':8#
loading dose 0.5 t 1 mg/
kg ? 9(#IE 0.3 mg/ kg/ hr
- IV push : :8#'EX >;# ] :;#
!I% 'EX >$#'E 5 $ 34 FJX>
}4(8% E] A@> K(E$Y E GH
!L&'L >F%D}4(A@>%D < 10
mg/ ml

- 8# 9b"9E }4( Pethidine กJ Barbiturate !f D!)# ก$G9XG(#
LD3Y :8#!ก=(ก ?ก?Dก'$
- AI:8#E :$)mD34_bN#HpIE'ENX:$3X $'$!f&_'%(ก !ก=(
Orthostatic hypotension
- !f&_'!Hn$ก J!3 ' ก HI(AI:8#E FกXbN#HpIEกX'$34_LD
!=_994' ก HI(9 ก)~@$ K(E!=_9:8#)$ (?_Y ] กX'$F%D:8#:$ 
DED!I% 34_"9_Y !"9'' L;XIE%(' ก I=?กก>I%G(# y# 9
" 9 yAIJA\9' ก HI(G(#F%#I NHFJJก :8#E ?X'GH
LD)~@$กJbN#HpIEF?X%D E
- ก 3Y :8#H˜"" ID!Hn$ก(LD!f=_9ก )J''ก)'>E 34_
G9XyNก!H%4_E$FH%>
- ก :;#:$DEDE I" 9 y3Y :8#!ก=(ก ?=(E G(# ' ก 
y'$E ' LLD!=_9!ก=(B E:$ 3 t 4 ;9. 8%>:8#E A@>"\(3# E
F%DLD!ก=(' ก "N>"\(B E:$ 8 t 12 ;9.
- E $4@LDG9X:;#:$' ก HI(;$=(!&@'>!$&_'>L ก' L!ก=( toxic
reaction
overdose : ก(DJJHD" 3"XI$ก% > ก(ก 8 E:L
9X $? )E E 8I:L!?#$;# pulmonary edema ' ก !M>"_$ ;ก
- ก !กMJE : !กMJE :8#f#$F"> 34_'\m8BN9= 15 - 30 °C
ก  ! : Pain relief, respiratory and mental status,
blood pressure, ?ILก 3Y > $)'>%Y G"#:$J > E' L
LY !Hn$?#'>:8#E DJ E 

กกUV:
- IM, SC ; onset 10 - 15 $ 34
peak 1 ;9. DED!I%
2 - 4 ;9.
- IV ; onset 5 $ 34

IM, IV, SC

- USFDA Preg Cat C/ D (prolonged use or high doses at
term)

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Pancuronium
Bromide
(Pavulon)
4 mg/ 2 ml 

/    

/    

!  

" #/ 7$

- !Hn$ neuromuscular blocker of choice
NSS, D5S, D5W - Direct IV : G9X?#'>!L&'L >
- Direct IV : :8#3\ก
Eก!I#$bN#HpIE34_94B IDก 3Y > $)'>?J8&'G?
RINGER
- IV Infusion : !L&'L >:$" %D% E34_ 20 - 60 $ 34 ? 9?#'>ก 
JกfX'> :;#"Y 8JA% Eก%# 9!$&@'!f&_'ก :"X
:;#G(#
- IV Infusion : ? 9ก 
endotracheal tube 8&':$ก bX ?( :;#"Y 8J
?'J"$'>)'>bN#HpIE
ก :"X!A&_'>;XIE8 E:L:$ ICU G9X943‚=ƒD>J
HI(8&'">JD>J
)$ (E 34_:;#:$bN#HpIEF?X%D E)~@$กJ$@Y 8$ก 
ก < 1 
:
- Test dose : 0.02 mg/ kg !f&_'I(ก ?'J"$'>
)$ (E !=_9?#$ : 0.03 mg/ kg/ dose :8#€@Y G(#3\ก
5 t 10 $ 34 ? 9?#'>ก 
maintenance : 0.03 t 0.09 mg/ kg/ dose
3\ก 30 $ 34 t 4 ;9. ? 9?#'>ก 

กJกก= 1 
  :
0.06 t 0.1 mg/ kg 8&':8# 0.05 mg/ kg 8%>L ก
:8# succinyl choline !f&_'ก :"X endotracheal
tube )$ (E ?X'GH:8# IV bolus 0.01 mg/ kg
$ $ 60t 100 $ 34 8%>L กก :8#E K("Fก
F%D8%>L ก$@$:8# 0.01 mg/ kg 3\ก 25 t 60$ 34
- :$ ICU : 0.05 - 0.1 mg/ kg IV bolus
? 9(#IE 0.8 - 1.7 µg/ kg/ min 8$~_>A@> 8&':8#
0.1 t 0.2 mg/ kg 3\ก 1 t 3 ;9.

กกE: '\m8BN9= 2 - 8 oC E 34_!8%&'AI3=@> 8%>L ก
!HŽ(8%'( 2 - 3 ;9.
- 8%>L ก!L&'L >F%#IA>?I 48 ;9. 
7$ :
- :;#!}f DbN#!;4_EI; <!3X $@$
- ก :8#E )$ ("N>LD!f=_9AI 9y4_F%DAI 9\$F>:$ก !ก=(
tachycardia
- E ' L94"XI$HDก'J)'> benzyl alcohol :8#DI>:$
bN#HpIE34_Ff#
- 8# 9b"9I9กJ diazepam
ก  ! : ก 3Y > $)'>DJJ neuromuscular,
"<< m;4f, electrolyte, Heart rate, BP, Ventilation
status, Cardiac status 
ก overdose : 8E\(8 E:L ก(ก 8 E:L DJJ8I:L
%#9!8%I

Direct IV, Intermittent IV

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Pralidoxime
Chioride
(2 - PAM)
1g

Ranitidine
(Xanidine,
Ranidine)
50 mg/ 2 ml 

/    

/    

!  

" #/7$

- Antidote, Anticholinesterase
- :;#กJ Organophosphorus poisoning IV ;
IM, SC ;

ก : 20 t 50 mg/ kg/ dose :8#:$ 1 t 2 ;9.
8%>L ก$@$:8#3\ก 8 t 12 ;9. y# 94 sign )'>
cholinergic !ก=()~@$ 
: 1 t 2 g :8#€@Y :$ 1 ;9. 8%>L ก$@$:8#
3\ก 8 t 12 ;9. y# 94 sign )'> cholinergic
!ก=()~@$
- ก Acetylcholinesterase inhibitor toxicity
: Adult : IV ; 1 t 2 mg ? 9(#IE 250 mg 3\ก 5
$ 34L$?'J"$'>
Direct IV, IV Infusion
- Histamine H2 Antagonist
- Duodenal, gastric ulcer, GERD

ก 1 
 16  : IV ; 2 t 4 mg/ kg/
day FJX>:8#3\ก 6 t 8 ;9. K(E)$ (E "N>"\(G9X
!ก=$ 150 mg/ day\ 
: IV continuous infusion for Zollinger t
Ellison : 1 mg/ kg/ hr ; I()$ ( gastric acid
output 34_ 4 ;9. y# > 10 mEq :8#!f=_9)$ (E
'4ก 0.5 mg/ kg/ hr K(E)$ (E "N>"\(G9X!ก=$ 2.5
mg/ kg/ hr
IM, IV intermittent bolus/ infusion
: 50 mg :8#3\ก 6 t 8 ;9.
IM , Direct IV, Intermittent IV, Continuous IV

NSS

- Direct IV : 1 g %D% E
:$
SWFI 20 ml 8&' G9X?#'>
!L&'L >:$bN#HpIE34_94B ID
pulmonary edema
- IV Infusion : !L&'L >b>
E 1 t 2 g :$ NSS 'EX
>$#'E 100 ml

- Direct IV : 1 g :8#$ $กIX 5 $ 34
- IV Infusion : 1 dose :8#$ $กIX 15
t 30 $ 34 G9XAI:8#!MIกIX 200 mg/
min

- Direct IV :;#!}f Dกm4bN#HpIE94 pulmonary edema 8&'
Infusion G9XG(#!9&_'!?4E9F%#IAI:;#3$34
- AI:;#B E:$ 24 ;9. 8%>L กbN#HpIEก=$E " f=
ก  ! : HR, RR, BP, continuous EKG
- ก :8#!MI] LD3Y :8#!ก=(laryngospasm, mucle rigidity
8&' tachycardia

NSS, D5W,
D10W

- IM : G9X?#'>!L&'L >
- Direct IV : !L&'L >กJ
" %D% E34_:;#G(# 20 ml
- Intermittent IV infusion
: 50 mg :$" %D% E34_
:;#G(#G9X$#'EกIX 100 ml
- Continuous IV infusion
: :$" %D% E34_:;#G(#'EX
>$#'E 250 ml (AI 9!)#
9)#$G9X!ก=$ 2.5 mg/ ml)

- Direct IV : :8#$ $กIX 5 $ 34
- Intermittent IV infusion : AI:8#E
$ $กIX 20 $ 34
- Continuous IV infusion : AI:8#E
6.25 mg/ hr :$!I% 24 ;9.

- USFDA Preg Cat C
- 8%>!L&'L >F%#IA>?I 48 ;9. 34_'\m8BN9=8#'>
- AI!กMJ:8#f#$F">
- ก :8#'EX >I(!MI' L3Y :8#!ก=( bradycardia F%D
tachycardia G(#
ก  ! : renal function impairement, hepatic
function impairment

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Streptomycin
1 g powder 

/    

/   

- Antituberculosis,aminoglycoside

ก : TB :
- Daily therapy : 20 t 40 mg/ kg/ day FJX>:8#
3\ก 6 t 12 ;9. K(E)$ ("N>"\(G9X!ก=$ 1 g
- Directly observed therapy (DOT) : 25 t 30
mg/ kg "H( 8C%D 2 A@> K(E)$ ("N>"\(G9X
!ก=$ 1.5 g/ dose
- DOT : 3 A@>/ "H( 8C, )$ (E 25 t 30 mg/
kg K(E)$ ("N>"\(G9X!ก=$ 1 g 
: TB :
- Daily therapy : 15 mg/ kg/ day K(E)$ (
"N>"\(G9X!ก=$ 1 g
- Directly observed therapy (DOT) : 25 t 30
mg/ kg "H( 8C%D 2 A@> K(E)$ ("N>"\(G9X
!ก=$ 1.5 g/ dose
- DOT : 3 A@>/ "H( 8C, )$ (E 25 t 30 mg/
kg K(E)$ ("N>"\(G9X!ก=$ 1 g
- Enterococcal endocarditis : 1 g :8#3\ก 12
;9. $ $ 2 "H( 8C, : 500 mg :8#3\ก 12 ;9.
$ $ 4 "H( 8C K(E:8#XI9กJ penicillin
YC : 10 mg/ kg/ day K(E)$ ("N>"\(G9X
!ก=$ 750 mg

NSS,D5W

IM 

!
- IM : 1 g :$$@Y ก%_$,
NSS 3.5 - 4.5 ml 

- IM : }4(!)# ก%# 9!$&@'9()$ (:8<X 

" #/7$
- 8%>%D% EF%#IAI:;#B E:$ 48 ;9. 34_'\m8BN9=8#'>F%D
14 I$!9&_'!กMJ:$?N#!EM$
ก  ! : hearing (audiogram), BUN, Cr

- USFDA Preg Cat D

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

7.5 % Sodium
bicarbonate
(0.9 mEq/ ml)
and 44.6 mEq/
50 ml

Sulperazone
(Cefoperazone
0.5 g +
Sulbactam 0.5
g) 

/    

/    

!  

" #/7$

- !Hn$ alkalinizing agent ก B ID
metabolic acidosis, hyperkalemia
- Cardiac arrest
Infants and children: IV ; 0.5 t 1.0
mEq/ kg/ dose 
: IV ; initial 1 mEq/ kg/ dose,
maintenance 0.5 mEq/ kg/ dose
- Metabolic acidosis
Infants and children : HCO3- (mEq)
= 0.3 x weight (kg) x base deficit
(mEq/L) 8&' HCO3- (mEq) = 0.5 x
weght (kg) x [24-serum HCO3(mEq/L)] 
: HCO3- (mEq) = 0.2 x weight
(kg) x base deficit (mEq/L) 8&'
HCO3- (mEq) = 0.5 x weight (kg) x
[24-serum HCO3- (mEq/L)]
Direct IV, IV infusion
- )$ (ก :8#E 2 - 4 g/ day
3\ก 12 ;9.

D5S, D5S/2,
D5W, D10W

- Direct IV :$bN#:8<XF%D!(MกG9X
LY !Hn$?#'>!L&'L > LD:;#:$AI 9!)#9)#$ 1
mEq/ ml :$ neonate 8&'!(Mก' E\$#'E
กIX 2 H| LD:;#:$AI 9!)#9)#$ 0.5 mEq/
ml 8&'!L&'L >" %D% E(#IE sterile
water :$'? "XI$ 1:1

- Direct IV : AI:8#E 'EX >;# ]
:$กm4 cardiac arrest ' LLD
:8#E 'EX >!MIF%DAI?=(? 9
ก !ก=(' ก )# >!A4E>L กก 
:8#E 'EX >!MIK(E:;#E )$ ( 1
mEq/ kg :8#:$!I% 9 กกIX 1 t
3 $ 34

- 8%>L ก!L&'L >F%#IA>?I 24 ;9.
- ก :8#'EX >I(!MI (10 ml/ $ 34) ' L3Y :8#
hypernatremia, CSF pressure %(%> F%D' L!ก=(
intracranial hemorrhage 
7$ : :$ก :8#E €@Y AI:8#E :$)$ ($#'E]!f&_'
8%4ก!%4_E>ก !ก=(B ID overdose F%D metabolic alkalosis
ก :8#E )$ (9 ก!ก=$GHL3Y :8#!ก=(B ID hypokalemia F%D
' L3Y :8#bN#HpIE!ก=(B ID8I:L!?#$b=(L>8ID
- AIDI>ก _I)'>E ''ก$'ก!"#$!%&'(
ก  ! : ?=(? 9B ID) ("9(\%)'> electrolyte
K(E!}f D hypokalemia F%D hypocalcemia ?=(? 9 pH,
ABG F%DD(J sodium bicarbonate ก 3Y > $)'>G?
K(E!}f Dก :;#:$DEDE I

IM, Direct IV, IV Infusion

- Continuous infusion !L&'L >:$ NSS,
D5NSS K(E94AI 9!)#9)#$"N>"\(!3X กJ
0.5 mEq/ ml :$ neonate 8&'!(Mก' E\
$#'EกIX 2 H| :;#:$AI 9!)#9)#$ 4.2 %
8&'!L&'L >" %D% E 7.5 % sodium
bicarbonate (#IE D5W :$'? "XI$ 1:1
K(EAI 9!)#9)#$"N>"\(!3X กJ 0.5 mEq/
ml

D5W, NSS,
D5S/4, D5S

- Continuous infusion :
'? !MI)'>ก :8#E !3X กJ 2
t 5 mEq/ kg :$!I% 9 กกIX 4
t 8 ;9. G9XAI:8#9 กกIX 50
mEq/hour ก :8#:$!(MกAI94
'? !MI)'>ก :8#E %(%> K(E
'? !MI"N>"\()'>ก :8#E
!3X กJ 1 mEq/ kg/ hr

- IM : 1 vial :$$@Y ก%_$ 1.5 - 2 ml
- Direct IV : 3 $ 34
- Direct IV : 1 vial :$$@Y ก%_$ 3 t 3.5 ml - Infusion : 15 - 60 $ 34
- Infusion: :$" %D% E34_:;#G(#'EX >$#'E
10 ml

- USFDA Preg Cat C
- 8%>%D% EF%D!L&'L >F%#IA>?I 24 ;9. 34_'\m8BN9=8#'>
F%D?N#!EM$

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

!  

" #/7$

Streptokinas
(Streptase ) 1.5 mu

- Thrombolytic agent :;#:$B ID
severe deep vein thrombosis,
pulmonary emboli, myocardial
infarction F%DB ID34_94ก '\(?$)'>
%=_9!%&'(
- Acute MI : IV 1.5 mU $ $ 60 $ 34
- Acute pulmonary embolism : IV 3
mU $ $ 24 ;9.

D5W, NSS

- %D% EE (#IE NSS H=9 ? 5 ml
K(E!?=9'EX >;# ] J=!Im)# >)I(
F%#I89\$F%D!'4E>)I('EX >;# ]
G9XAI!)EX )I( L ก$@$!L&'L >
?X'(#IE NSS/ D5W :8#G(#H=9 ?
3@>89(!Hn$ 45 ml F?X' LLD
!L&'L >9 กกIX $4@ K(E:;#
" %D% EH=9 ? 45 ml !L&'L >
:$H=9 ?"N>"\( 500 ml
AI 9!)#9)#$"N>"\(A&'
1.5 mu/ 50 ml
- IV Infusion pump !L&'L >E (#IE
" %D% E D5W, NSS, Ringer's
Lactate

- continuous IV Infusion "Y 8J Pulmonary
embolism, deep vein thrombosis, arterial
embolism 8&' thrombosis 94(>$4@ :
- loading dose :$ pulmonary embolism,
deep vein thrombosis, arterial embolism
8&' thrombosis :8#E 34_!L&'L >F%#IbX $3 >
peripheral IV line K(E:;# infusion pump K(E
:8# 250,000 IU :$!I% 9 กกIX 30 $ 34
- maintenance dose :8#bX $ infusion pump
:$'? !MI 100,000 IU/ hr "Y 8Jก
pulmonary embolism LD:8# continuous IV
Infusion !Hn$!I% 24 ;9. "Y 8J arterial
embolism 8&' thrombosis LD:8# continuous
IV Infusion !Hn$!I% 24 t 72 ;9. "Y 8J
deep vein thrombosis LD:8#!Hn$!I% 72 ;9.
-"Y 8J coronary artery thrombi :8#E 34_!L&'
L >F%#IbX $3 > peripheral IV line K(E:;#
infusion pump K(E:8#'? !MI!Hn$ 1.5 mU
?X';9. !Hn$!I% 1 ;9. G9XLY !Hn$?#'>:8#
maintenance dose

- 8%>%D% EF%#IA>?I 24 ;9. :$?N#!EM$ F%D 8 ;9.
34_'\m8BN9=G9X!ก=$ 25 OC Hl'>ก$F">
- !9&_'!=_9?#$ก ก ' L!ก=(AI 9($K%8=??_Y 8I
:L!?#$!MI8&';# b=(Hก?= L$' Ly~>;M'AG(# (>$@$L~>
AI8E(E 'EX >;# ] !9&_'!=_9?#$ก ก F%D
" 9 y :8#E ก%\X9A'C?=KA"!?''E(C!f&_'ก 
Hl'>ก$G(# !;X$ :8#E Methylprednisolone Inj 100 200 mg กX'$!=_9:8#E Streptokinase 10 $ 34
- F9#LDG9XF$D$Y :8#:;# heparin :$D8IX >:8#E
streptokinase F?X' L:;#8%>L ก$@$G(#!f&_'%('?
!"4_E>?X'ก ก%J!Hn$€@Y )'> thrombosis F%D
pulmonary emboli K(E:8# heparin 8%>L ก8E\(:8#
E streptokinase GHF%#IHD9 m 3-4 ;9. 8&'
!9&_'?ILAX PTT G(#$#'EกIX 100 I=$ 34
overdose : !%&'(กY !( G8% !%&'(''ก? 9G‘˜$ L@Y
!%&'(
ก  ! : BP, PT, PTT, fibrinogen level
- 3Y Skin test 100 u (15 t 20 min) กX'$}4(

-% ! IM

Direct IV, Intermittent IV

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Succinycholine
(Suxamethonium
chioride)
50 mg/ ml, 10 ml 

/    

/   

- :;#"Y 8JA% Eก%# 9!$&@'!f&_'ก :"X
NSS, D5W, D5S
endotracheal tube 8&':$ก bX ?(
- IM : 2.5 - 4 mg/ kg )$ (E I9G9X!ก=$
150 mg AI}4(:$ก%# 9!$&@' deltoid F%D}4(
:8#%~ก

ก : IV ; !=_9?#$ 1-2 mg/ kg ? 9(#IE
0.3 t 0.6 mg/ kg 3\ก 5-10 $ 34 ? 9?#'>ก 
!$&_'>L กE 94AI 9!"4_E>3Y :8#!ก=( malignant
hyperthermia L~>G9XF$D$Y :8#:;#E FJJ
continuous infusion :$!(Mก 
: IV ; 1 t 1.5 mg/ kg ? 9(#IE 0.04 0.07 mg/ kg 3\ก 5-10 $ 34 K(E)$ (E I9
G9X!ก=$ 150 mg
Continuous infusion ; 10 - 100 µg/ kg/ min
8&'
0.5 - 10 mg/ min

Direct IV, IV Infusion, IM 

! 

- Direct IV : G9X?#'>!L&'L >
- Direct IV : :8#:$!I% 10 t 30 I=$ 34
- IV Infusion : !L&'L >:8#94AI 9 bX $3 >" E:8#" $@Y
!)#9)#$ 0.1 - 0.2 %
- Continuous IV Infusion : :;#AI 9!)#9)#$
- IM : }4(:8#%~ก
1 t 2 mg/ ml :8#E bX $3 >" E:8#" $@Y
K(E!=_9:8#E :$'? !MI 2.5 mg/ min
8%>L ก$@$HJ)$ (!Hn$ 0.5 t 1.0 mg/
min )~@$กJก ?'J"$'>)'>bN#HpIE G9XAI
!ก=$ 10 mg/ min
* G9XF$D$Y ก :8#E FJJ intermittent IV
Infusion !$&_'>L กก :8#E !Hn$DEDLD3Y
:8#!ก=( tachyphylaxis F%D prolonged
apnea
- G9X!)# ก$กJ Calcium carbonate,
Pentobarbital F%D Thiopental 

" #/ 7$
- 8%>!L&'L >F%#IA>?I34_'\m8BN9=8#'> 24 ;9.
- 8 ก:;#" %D% EG9X89(:8#3=@>" %D% E$@$ 
7$ :
- B ID34_!Hn$" !8?\3Y :8#!ก=( prolonged
neuromuscular blocked G(#FกX electrolyte
imbalance (hypokalemia, hypoclcemia,
hypermagnesemia, hypernatremia), Hypothermia,
KA)'>bN#HpIE!;X$ myasthenia gravis, polymyositis
8&'ก :;#E 34_94 drug interaction G(#FกX Inhaled
anesthetics, calcium channel blockers,
antiarrythmics, aminoglycosides, vancomycin,
clindamycin, tetracycline, cyclosporin
- ก :8# atropine กX'$:8#E LD;XIE%(ก !ก=(
bradycardia
- ก :8#E ก%\X9 nondepolarizing neuromuscular
blocking agents (pancuronium, vecuronium,
atracurium) กX'$:8#E 3 - 5 $ 34 LD;XIEHl'>ก$HD
%(ก !ก=(' ก (>?X'GH$4@G(# : fasciculations,
myalgia, myoglobinuria, increased intragastric
pressure, increased intracranial pressure
ก  ! : blood pressure, heart rate, '\m8BN9=
F%D ?=(? 9D(J)'> muscle relaxation
overdose : respiratory paralysis, cardiac arrest
กกE : 2 t 8 °C y# 'ENX:$NHFJJb>F8#>G9X
LY !Hn$?#'>F;X!EM$
- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Thiopental
sodium
1 g powder 

/    

/    

! 

- ก :;#E :8# Test dose กX'$K(E :;#
25 t 75 mg (1 t 3 ml )'>" %D% E!)#9)#$
2.5 %) !f&_'?IL"'JAI 93$?X'E F%Dก 
Ff#E K(E">!ก?:$!I% 60 I=$ 34
- ;ก$Y ก "%J :
Infant : 5 t8 mg/ kg

ก 1  12  : 5 t 6 mg/ kg 
: 3 t 5 mg/ kg
- ก "B IDก "%J :

ก : 1 mg/ kg ? 9AI 9LY !Hn$ 
: 25 - 100 mg ? 9LY !Hn$
- ก ' ก ;ก :

ก : 2 t 3 mg/ kg/ dose 
: 75 t 250 mg/ dose €@Y G(#? 9
LY !Hn$

0.45 % NaCI,
NSS, D5W

- Direct IV : :;#)$ (E 500 mg
9 %D% E(#IE sterile water,
D5W 8&' NSS LY $I$'EX >$#'E
20 ml LDG(#AI 9!)#9)#$ 2.5 %
y# :8#:$AI 9!)#9)#$"N>LY 3Y :8#
!ก=( hemolysis
- Intermittent IV Infusion : :;#:$
AI 9!)#9)#$ 2 t 5 % :$ D5W,
NSS K(EHก?=:;#AI 9!)#9)#$ 2
8&' 2.5 %
- Continuous IV Infusion : :;#b>
E 34_%D% EF%#I)$ ( 200 t 400
mg 9 !L&'L >(#IE NSS 8&'
D5W LY $I$ 100 ml LDG(#AI 9
!)#9)#$ 0.2 t 0.4 % G9XAI:;#
sterile water !Hn$?I!L&'L >
!$&_'>L กLD3Y :8#!ก=( hemolysis

- direct IV :;#AI 9!)#9)#$
2.5 % K(E:8#)$ (E 25 mg
:$!I% 9 กกIX 1 $ 34 K(EHJ
)$ (E ? 9b%34_?#'>ก  ก 
:8#E 'EX >I(!MILD3Y :8#!ก=(
' ก  overdose €~_>LD94ก ก( 
DJJ8 E:L'EX >\$F> AI 9
($K%8=??_Y %( cardiac output
ก :8#E FJJ direct IV LD:8#E
bX $3 >" E:8#" $@Y
- Intermittent IV Infusion :;#
AI 9!)#9)#$ 2.5 % :8#E :$
!I% 9 กกIX 10 t 60 $ 34 K(E
AI 9!)#9)#$"N>"\(!3X กJ 50
mg/ min
- Continuous IV Infusion :;#
" %D% E34_94AI 9!)#9)#$ 0.2 t
0.4 % K(Ey# :8#:$AI 9!)#9)#$
0.2 % :8#:$'? !MIG9X!ก=$ 50
ml/ min

Direct IV, IV Infusion 

" #/ 7$
- b>E 34_%D% EF%#ILD94AI 9A>?I 3 I$ 34_'\m8BN9=8#'>F%D
7 I$ :$?N#!EM$
- !$&_'>L กE G9X94 preservative 8%>L ก34_!L&'L >F%#IAI:;#
B E:$ 24 ;9. 
7$ :
- ก :8# prolong continuous infusion ' L3Y :8#!ก=(
respiratory F%D circulatory depression
- bN#HpIE34_94B ID3$?X'E barbiturates 8&' alcohol ' L
LY !Hn$?#'>:8#E :$)$ ("N>)~@$
- 8%4ก!%4_E>ก :8#E FJJ subcutaneous F%D intra-arterial
!$&_'>L กE ' L3Y :8#!ก=(!$&@'!E&_'? EF%D8%\(%'ก
ก  ! : ?=(? 9I( vital sign 3\ก 3 - 5 $ 34
กกE$กA : '\m8BN9= 15 t 30 °C

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/  

Terbutaline
(Bricanyl)
0.5 mg/ ml

- Bronchodilator, Tocolytic agent
- Bronchostriction

ก < 12  : SC ; 0.005 t 0.01
mg/ kg/ dose :8#3\ก 15 t 20 $ 34 :8#
3 dose )$ ("N>"\(G9X!ก=$ 0.3 mg/ kg

ก > 12    : SC ;
0.25 mg/ kg/ dose y# LY !Hn$' L:8#
€@Y '4กA@>B E:$ 15 t 30 $ 34 )$ (
"N>"\(G9X!ก=$ 0.5 mg/ kg
- Premature labor 
: IV ; 2.5 t 10 µg/ min !f=_9)~@$
G(#3\ก 10 t 20 $ 34 )$ ("N>"\(G9X!ก=$
17.5 t 30 µg/ min
SC, IV Infusion
- :;#:$ Hemophillia Patient :$D8IX > 
D8IX >ก y'$‘˜$!f&_'%( F%DHl'>ก$
!%&'(''ก

ก   : IV ; 10 mg/ kg :8#
3$34กX'$bX ?( 8%>L ก$@$:8# 25 mg/
kg/ dose K(Eก JHD3 $I$%D 3 t
4 A@>

D5W, NSS

- Infusion : E 5 mg %D% E:$
D5W :8#G(#AI 9!)#9)#$ 5 µg/ ml

- IV Infusion : :8#$ $'EX >$#'E 12 ;9.

- 8%>L ก!L&'L >F%#IA>?I 48 ;9.
- $=E9:;# D5W LD:;# NSS !9&_'bN#HpIE94)#'8# 9:;#
Dextrose !3X $@$
ก  ! : lung sound, pulse, BP, wheezing
after admin call physician
- USFDA Preg Cat B

NSS, D5W,
D10W,
RINGER

IV : !L&'L >'EX >$#'E 50 ml :$
" %D% E34_:;#G(#

- G9X!ก=$ 1 ml/ $ 34 ก :8#'EX >I(!MI' L
3Y :8#!ก=( hypotension

- ก :8#3 > IM D9(DI>ก !ก=( tissues or
nerves damage AI8%4ก!%4_E>ก }4(:$34_!(=9

Tranexamic acid
250 mg/ 5 ml (5%)

Intermittent IV, IM 

!  

" #/7$

- USFDA Preg Cat B

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Trastuzumab
(Herceptin) 440 mg
+ SWFI + diluent
benzyl alcohol 

/    

/ 
- Antineoplastic agent
- Initial loading dose : 4 mg/ kg
- IV Maintenance dose : 2 mg/ kg 

SWFI 

!
- b"9!L&'L >กJ SWFI
20 ml 8# 9!)EX LDG(#
" %D% E = 21mg/ ml 

- IV Infusion loading dose :8#$ $ 90 $ 34
- Maintenance dose :8#$ $ 30 $ 34 y# 3$
G(#

IV, IV Infusion
Vancomycin
(Vancocin inj)
500 mg

NSS,D5W,D - Intermittent IV : %D% E
- Antibiotic, Miscellaneous
10W, D5S, 500 mg :$ D5W 8&' NSS
- )$ (ก :;#3_IGH :
Sodium
Infants >1 month and Children: IV ;
10 ml F%#IL~>HJH=9 ?(#IE
Bicarbonate NSS 8&' D5W :8#AJ
10 t 15 mg/ kg 3\ก 6 ;9.
3.75 %
Adult : IV : 2 t 3 g/ day (20 t 45 mg/
100 - 200 ml
kg/ day) FJX>:8#3\ก 6 t 12 ;9.)$ (
- IV Infusion : 1 - 2 g :$
"N>"\(G9X!ก=$ 3 g/ day
" %D% E34_:;#G(# drip 24 ;9
Intermittent IV, IV Infusion

- IV Infusion : 24 ;9. (daily dose)
- Intermittent IV : 'EX >$#'E 60 $ 34 AI 9
!)#9)#$"\(3# EG9X!ก=$ 5 mg/ ml 

" #/7$
- กX'$b"9!กMJE :$?N#!EM$ 2 - 8 C 8&' 38 t 48 F
8%>b"9กJ SWFI F%#I!กMJG(# 28 I$:$?N#!EM$
- 8# 9b"9I9กJ D5W F?X dilute (#IE NSS
'ENXG(# 24 ;9. 34_'\m8BN9=8#'> F?XAI!กMJ:$?N#!EM$
'\m8BN9= 2 - 8 C
- monitor : cadiac dysfunction and vital sign
- USFDA Preg Cat B
Vancomycin
(Vancocin inj)
500 mg

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi  

/    

/   

!  

" #/7$

Vecuronium
Bromide
(Vecuron, Norcuron)
4 mg/ml

- Neuromuscular-Blocking Agents,

D5W,NSS,
D5S,
RINGER

- Direct IV : %D% EE 10 mg :$
$@Y ก%_$ 10 ml
- IV Infusion : %D% EE 10 t 20
mg :$" %D% E34_:;#G(#'EX >$#'E
100 ml

- Direct IV : ½ - 1 $ 34
- IV Infusion : '? !MI)'>ก :8#E 0.8 t

- 8%>!L&'L >F%#IA>?I 1 I$K(E!กMJGI#:$?N#!EM$
- !L&'L >:$ bacteriostatic water for injection A>
?I 5 I$

"Y 8JA% Eก%# 9!$&@'!f&_'ก :"X
endotracheal tube 8&':$ก bX ?(
:;#"Y 8Jก :"X!A&_'>;XIE8 E:L 
: !=_9?#$:8#E :$)$ ( 0.08 t
0.1 mg/ kg )$ (E ?X'GH:8# 0.01 t
0.015 mg/ kg K(E:8#8%>L ก)$ (E
!=_9?#$ 20 t 40 $ 34 ?X'L ก$@$:8#3\ก
12 t 15 $ 34? 9AI 9LY !Hn$8&':8#
FJJ continuous infusion !=_9:$)$ (
1 µg/ kg/ min (0.001 mg/ kg/ min)

ก : 0.5 t 1 mg/ kg/ hour !(Mก' E\
10 t 17 H| )$ (E !89&'$)'>bN#:8<X
!(Mก' E\$#'EกIX 10 H| ' L?#'>:;#
)$ (E !=_9?#$"N>กIX
Direct IV ,IV Infusion

1.2 µg/ kg/ min

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi 

Verapamil
(Isoptin)
5 mg/ 2 ml 

/    

/  

- Antiarrhythmic Drugs
- Supraventricular Tachyarrhythmia
!(Mก' E\ < 1 H| : IV ; 0.1 t 0.2 mg/ kg
:8#€@Y 3\ก 30 $ 34
!(Mก' E\ 1 t 15 H| : IV ; 0.1 t 0.3 mg/
kg )$ ("N>"\(G9X!ก=$ 5 mg/ dose :8#
€@Y G(#'4กA@>8%>L กA@>Fก 15 $ 34
K(E)$ ("N>"\(G9X!ก=$ 10 mg/ dose
bN#:8<X : IV ; 2.5 t 5 mg :8#€@Y G(#'4ก
A@>8%>L กA@>Fก 15 t 30 $ 34 :$
)$ ( 5 t 10 mg K(E)$ (E I9
"N>"\(G9X!ก=$ 20 mg

D5W, NSS,
RINGER

Direct IV,IV Infusion 

!
- IV : G9X?#'>!L&'L >K(E:8##
3 > Y - site 8&' 3 - way
- Infusion : !L&'L >:8##G(#
1 mg/ml 

- Direct IV : 2  3 $ 34
- Infusion : 5 - 10 mg/ ;9 

" #/7$
- G9XAI!กMJ" %D% E34_!8%&':; #F%D'EX :;#y#
" %D% E94"4 8&'94?Dก'$8# 9:;#XI9กJ sodium
bicarbonate solution in saline 3 > IV line DI>
!ก=( hypotension, dizziness ,flushing
- !กMJก GI#34_'\m8BN9=8#'> 8# 9F;XF)M>

- USFDA Preg Cat C

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi
" ( "ก7)
Ampicillin + sulbactam (Unasyn)

ก!(Reconstitution)"ก!@" 
IV bolus 
/7!!
7!7 $$ !
SWFI, NSS, 5DW, 5DN/2,
Lactated Ringer (1.5 g : 3.2 ml )

Amoxycillin + clavulanic (Augmentin,
Cavumox)

SWFI (1.2 g : 20 ml)
- IV ;# ] !(=$E 3 - 4 $ 34

:;#B E:$ 20 $ 348%>b"9

Aztreonam (Azactam)

NSS, SWFI (1 g : 6 - 10 ml)

48 ;9. 34_ 15 - 30 C
7 I$ 34_ 2 - 8 C

Cefamandole (Mandol)

SWFI, 5DW, NSS (1g : 10 ml)

Cefoperazone (Cefobid)

5DW, 10DW, 5DS, NSS, SWFI,
Normosol R , Normosol M and
5%dextrose inj., 5 % dextrose and
0.2% NSS inj (1 g : 2.8-5.0 ml)

24 ;9. 34_ 25 C
96 ;9. 34_ 5 C
24 ;9. 34_ 15-25 C
5 I$ 34_ 2-8 C
!}f D34_AI 9!)#9)#$34_กY 8$( 

_"_ (Dilution of IV fluids) @" 
IV Infusion 
/7!!
7!7 $$ !
SWFI, NSS, 5DW, 5DN/2,
- SWFI, NSS: 8 ;9. 34_ 25 C F%D
Lactated Ringer
48 - 72 ;9.34_ 4 C
- 5DW: 2-4 ;9.34_ 25 C F%D 4 ;9.34_ 4 C
- 5DN/2: 4 ;9.34_ 25 C F%D 4 ;9.34_ 4 C
- LR: 8 ;9.34_ 25 C F%D 24 ;9.34_ 4 C
NSS, Sodium lactate 1/6M, Ringer's soln.,
- SWFI, NSS, Sodium lactate 1/6M :
Lactated Ringer , KCl or
4 ;9.34_ 25 C
NaCL infusion (1.2 g : 100 ml)
- SWFI, NSS : 8 ;9.34_ 5 C
- กm4 IV drip : E 1.2 g %D% E:$ water 8&' - Ringer's soln , LR, KCl or NaCL :
NSS 100 ml drip 30 - 40 $ 34
3 ;9. 34_ 25 C
SWFI, NSS, Ringer's inj, Lactated Ringer's inj, 48 ;9.34_ 15 - 30 C
5DW, 10DW, 5DS, 5D/N/2, 5D/N/4,
7 I$.34_ 2 - 8 C
Sod.lactate(M/6) !Hn$?#$ (1 g : 50 ml 'EX >$#'E) $@Y E 34_ Conc. > 2% w/v :8#:;#3$34
AI 9!)#9)#$"\(3# EG9X!ก=$ 2 % w/v
8%>b"9 Eก!I#$:$ WFI, NSS y# !กMJ
'\m8BN9= ?#'>:;#B E:$ 48 ;9. 8&'
y# !กMJ:$?N#!EM$ ?#'>:;#B E:$ 7 I$
NSS, 5DW, 10DW, 5DS, 5DN/2, 5DN/4,
sod.lactate inj (M/6)
5DW, 10DW, 5DS, NSS, Normosol R,
24 ;9. 34_ 15-25 C
Normosol M and 5%dextrose inj, 5%dextrose 5 I$ 34_ 2-8 C
and 0.2% NSS inj, LR, 5%dextrose and
!}f D34_AI 9!)#9)#$34_กY 8$( (N E%D!'4E(
lactated ringer's inj
!'ก" กY กJE

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi

Cefoperazone + sulbactam
(Sulperazon)

ก!(Reconstitution)"ก!@" 
IV bolus 
/7!!
7!7 $$ !
5DW, 10DW, 5DS, NSS, WFI
- 24 ;9. 34_ 15 - 25 C F%D
1 g/ 2.8 8&' 5 ml
5 I$ 34_ 2-8 C
!}f D34_AI 9!)#9)#$34_กY 8$(
SWFI ( 1 g : 4 ml)
- 24 ;9. 34_'\m8BN9=8#'>
* "'Jy 9L กJ=3

Cefotiam (Ceradolan)

SWFI, NSS, 5DW (1 g : 5 -20mL)

Cefpirome (Cefrom)

SWFI (1 g : 10 ml)

Cefuroxime (Zinacef)

SWFI (750 mg : 6 ml)

Fosfomicin
Fusidate sodium (Fucidin) 

[$ infuse  $8

SWFI, NSS, 5DW (1-2g:20mL)
Buffer solution (500 mg : 10 ml)

" ( "ก7)
Cefoperazone (Medocef)

Gatifloxacin (Tequin) 

_"_ (Dilution of IV fluids) @" 
IV Infusion 
/7!!
7!7 $$ !
5DW, 10DW, 5DS, NSS , WFI
- 24 ;9. 34_ 15-25 C
F%D 5 I$ 34_ 2-8 C
!}f D34_AI 9!)#9)#$34_กY 8$(
5DW, NSS, SWFI, 5DS,5DN/4
(1 g : 20 ml)
IV push:8%> reconstituted }4('EX >$#'E
3$ 34
IV drip: %D% E?X'$@Y E !(4EIก$ L$G(# 20 ml
drip 15 - 60 $ 34
:;#B E:$ 8 ;9. G9XDJ\'\m8BN9=
Glucose solution, electrolyte solution or amino
acid prep


6 ;9. 34_ <25 CF%D 24 ;9. 34_ 2-8 SWFI, NSS, Ringer's soln, 5DW, 10DW, 6DS 6 ;9.34_ <25 C F%D 24 ;9. 34_ 2-8 C
C
(1 g :100 ml)
- 5 ;9.34_ < 25  C
SWFI. (1.5 g : 50 ml) NSS, 5DW, 0.18%NSS + - 24 ;9. 34_ < 25  C F%D 72 ;9. :$?N#!EM$
F%D 48 ;9. :$?N#!EM$
4% dextrose inj.,
24 ;9. 34_'\m8BN9=8#'>
y# !L&'L >กIX $4@ (1.5g/ 50ml) LD'ENX Sodium lactate inj etc.
G9XG(#DJ\AI 9!)#9)#$

G(# 24 hr 34_ < 25 C F%D
72 hr y# !กMJ:$?N#!EM$
7 I$G9XG(#DJ\'\m8BN9=
NSS, 5DW (1-2 g: 100 - 500 ml )
:;#89(B E:$ 24 ;9.
NSS, 5DW (500 mg : 250 - 500 ml ) infuse :;#89(B E:$ 24 ;9.
2 ;9.
WFI, NSS, 5DW, Lactated Ringer and 5%
14 I$ :$?N#!EM$ (2 - 8 C) 8&'
Dextrose injection,
34_ 20 - 26 C
5% Sod.Bicarbonate injection

Injectable Drugs Data of Banglamung Hospital, Department of Pharmacy, Chonburi
" ( "ก7)
Levofloxacin (Cravit)
Meropenem

Piperazillin

ก!(Reconstitution)"ก!@" 
IV bolus 
/7!!
7!7 $$ !
AI:;#:8#89(B E:$ 3 ;9.
8%>94ก !HŽ(:;#E
SWFI (250 mg : 5 ml)
- 8 ;9. 34_ 15-25 C
F%D 48 ;9.34_ 4 C

SWFI (2 g : 10 ml) 

_"_ (Dilution of IV fluids) @" 
IV Infusion 
/7!!
7!7 $$ !
NSS, 5DW, 2.5% Dextrose in Ringer solution AI:;#:8#89(B E:$ 3 ;9. 8%>94ก !HŽ(
infuse 60 $ 34
:;#E
NSS, 5DW, 10DW,5DS, 5DN/4, 2.5% or
- NSS: 8 ;9.34_ 15-25 C F%D 48 ;9. 34_ 4
10% mannitol !Hn$?#$ (250 mg -1 g :
C
50-200 ml )
- 5DW, 5DS, 5DN/4, 2.5% or
10% mannitol : 3 ;9.34_ 15-25 C
14 ;9.34_ 4 C
- 10DW: 2 ;9.34_ 15-25 C
F%D 8 ;9.34_ 4 C
IV fluid 34_:;#G(# : 5DW, NSS, 5DS,
!9&_'b"9กJ cephazolin, flucloxacillin,
Lactated Ringer, etc (2 g : 'EX >$#'E 50 ml) cephamandole, 8&' cefoxitin :$ 5DW,
NSS 8&' Lactated Ringer " 9 y'ENXG(#
24 ;9. 34_'\m8BN9=8#'> 8&' 48 ;9. 34_ 4 C

Sign up to vote on this title
UsefulNot useful